{"gene":"PMAIP1","run_date":"2026-06-10T06:43:35","timeline":{"discoveries":[{"year":2003,"finding":"Noxa is a p53 transcriptional target encoding a BH3-only proapoptotic Bcl-2 family protein required for DNA damage-induced apoptosis; Noxa-deficient mice and MEFs show decreased apoptosis in response to DNA damage and oncogene-dependent stress, and Noxa loss combined with Bax loss further increases resistance, placing Noxa upstream of Bax in the intrinsic apoptotic pathway.","method":"Gene-targeted knockout mice (Noxa-/-), MEF apoptosis assays, in vivo irradiation model","journal":"Genes & development","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic loss-of-function with multiple orthogonal phenotypic readouts, replicated across multiple stress conditions and in vivo, independent of PMID:14500851","pmids":["12952892"],"is_preprint":false},{"year":2003,"finding":"Noxa and Puma are critical BH3-only mediators of p53-dependent apoptosis induced by DNA damage; Noxa deficiency reduces DNA damage-induced apoptosis in fibroblasts but not lymphocytes, while Puma deficiency is broader, also protecting against p53-independent cytotoxic insults.","method":"Gene-targeted knockout mice (noxa-/- and puma-/-), apoptosis assays in fibroblasts and lymphocytes","journal":"Science (New York, N.Y.)","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic KO with defined cell-type-specific phenotypes, independently replicated across two labs (PMID:12952892)","pmids":["14500851"],"is_preprint":false},{"year":2003,"finding":"The Noxa promoter responds directly to hypoxia via HIF-1alpha transcription factor binding, and Noxa mediates hypoxic cell death involving reactive oxygen species and cytochrome c release; antisense suppression of Noxa rescues cells from hypoxia-induced death and reduces infarction in an ischemia model.","method":"Promoter reporter assays, antisense oligonucleotide knockdown, cytochrome c release assay, in vivo ischemia model","journal":"The Journal of experimental medicine","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple methods (promoter assay, knockdown, in vivo), single lab","pmids":["14699081"],"is_preprint":false},{"year":2005,"finding":"Proteasome inhibitors induce p53-independent transcriptional upregulation of NOXA mRNA and protein in melanoma and myeloma cells, and NOXA induction is required for mitochondrial apoptosis (cytochrome c, Smac, AIF release, caspase cascade); antisense knockdown of NOXA reduces apoptotic response by 30–50%.","method":"Antisense oligonucleotide knockdown, Western blot, cytochrome c/Smac/AIF release assays, caspase activation assays","journal":"Cancer research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — functional knockdown with specific readouts, single lab, multiple cancer lines","pmids":["16024630"],"is_preprint":false},{"year":2006,"finding":"Noxa specifically interacts with the labile anti-apoptotic protein Mcl-1, and the Noxa/Mcl-1 axis functions as an apoptosis rheostat in dividing T cells under glucose limitation; Noxa knockdown protects from glucose deprivation-induced apoptosis while Mcl-1 knockdown sensitizes cells.","method":"siRNA knockdown, co-immunoprecipitation, apoptosis assays under glucose deprivation","journal":"Immunity","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal functional epistasis with Co-IP, replicated by multiple subsequent labs","pmids":["16782027"],"is_preprint":false},{"year":2006,"finding":"FKHRL1/FoxO3a transcription factor directly induces Noxa (and Bim) expression, and RNAi knockdown of Noxa decreases FKHRL1-induced apoptosis in neuroblastoma cells; Bcl-2 overexpression (but not dominant-negative FADD) blocks this death, establishing Noxa as a downstream effector linking FKHRL1 to the mitochondrial apoptotic pathway.","method":"Tamoxifen-regulated transgene, RNAi knockdown, Bcl-2 overexpression, cytochrome c release assay","journal":"Cell death and differentiation","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic epistasis with multiple approaches, single lab","pmids":["16888645"],"is_preprint":false},{"year":2007,"finding":"In bortezomib-treated myeloma cells, Noxa is induced and forms increased Mcl-1L/Noxa complexes, disrupts Mcl-1/Bak complexes, and displaces Bim from Mcl-1, thereby activating Bax/Bak and inducing apoptosis; Mcl-1 cleavage also occurs alongside Noxa induction.","method":"Co-immunoprecipitation, Western blot, siRNA knockdown, caspase activation assays","journal":"Cancer research","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal Co-IP demonstrating complex formation and displacement, multiple orthogonal methods, independently replicated","pmids":["17545623"],"is_preprint":false},{"year":2007,"finding":"Noxa induction by proteasome inhibitors is directly dependent on the oncogene c-MYC; conserved MYC-binding sites in the NOXA promoter were validated by ChIP and reporter assays; c-MYC knockdown abrogated NOXA induction, and forced c-MYC expression in normal cells enabled NOXA accumulation and apoptosis in response to proteasome blockage.","method":"ChIP, promoter-reporter assay, siRNA knockdown, c-MYC overexpression","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — ChIP validation of promoter binding plus gain/loss-of-function experiments, multiple orthogonal methods","pmids":["18042711"],"is_preprint":false},{"year":2007,"finding":"UVR-induced apoptosis in fibroblasts and skin keratinocytes proceeds via the Bcl-2-regulated (mitochondrial) pathway, with Noxa (a p53 target) playing the dominant initiating role; Noxa deficiency suppresses UVR-induced keratinocyte apoptosis in vivo and in primary MEFs, and in transformed cells where Puma is not induced, Noxa is the primary mediator.","method":"Noxa-/- knockout MEFs and mice, UV irradiation, TUNEL/apoptosis assays in skin","journal":"The Journal of cell biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic KO in vivo and in vitro, multiple cell types, clear epistasis","pmids":["17283183"],"is_preprint":false},{"year":2006,"finding":"Puma and Noxa differentially participate in dual p53-induced apoptotic pathways: in normal cells, Puma (but not Noxa) induces MOMP via a calcium/ER-dependent pathway; upon E1A oncoprotein expression, cells become susceptible to Noxa-mediated MOMP via an ER-independent pathway.","method":"Noxa-/-, Puma-/- MEFs, E1A expression, MOMP/cytochrome c assays, calcium chelation","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic epistasis with mechanistic pathway dissection, multiple orthogonal approaches","pmids":["17024184"],"is_preprint":false},{"year":2004,"finding":"E1A expression induces Noxa in p53-deficient cancer cells in a TAp73-dependent manner; E1A activates the TAp73 promoter via E2F1-binding sites, and TAp73 then transcriptionally activates Noxa, establishing p73 as a p53-independent transcriptional activator of Noxa.","method":"Promoter-reporter assay, E1A mutant analysis, endogenous mRNA/protein detection, p53-deficient cell lines","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — promoter assays and mutant analysis, single lab","pmids":["15572378"],"is_preprint":false},{"year":2008,"finding":"Bmi1 polycomb group protein directly binds the Noxa gene locus with accompanying H3K27 methylation, recruits other PcG products and Dnmt1, and promotes CpG methylation of the Noxa gene; Bmi1 loss increases Noxa expression leading to enhanced memory T cell death, and Noxa deletion rescues memory Th2 cell generation in Bmi1-/- mice.","method":"ChIP, CpG methylation analysis, Bmi1-/- and Noxa-/- genetic crosses, T cell survival assays","journal":"The Journal of experimental medicine","confidence":"High","confidence_rationale":"Tier 2 / Strong — ChIP demonstrates direct binding, genetic epistasis confirmed by double knockout rescue","pmids":["18411339"],"is_preprint":false},{"year":2010,"finding":"Cisplatin-induced Noxa expression is ERK-dependent and p53-independent; ERK inhibition or siRNA-mediated Noxa ablation both attenuate cisplatin-induced cell death and permit clonogenic survival, establishing an ERK→Noxa axis as critical for platinum drug cytotoxicity.","method":"siRNA knockdown, ERK inhibitors, clonogenic survival assay, Western blot","journal":"Oncogene","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — siRNA knockdown with functional readout, ERK inhibitor epistasis, single lab","pmids":["20802529"],"is_preprint":false},{"year":2010,"finding":"NOXA protein is ubiquitinated on at least three primary lysine residues and has a short half-life (~1–2 h) subject to proteasomal degradation; in CLL cells, bortezomib causes a rapid, transcription-independent increase in NOXA protein that precedes cytochrome c release and caspase activation.","method":"Western blot, siRNA knockdown, ubiquitination analysis, protein half-life measurement","journal":"Haematologica","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ubiquitination mapping and functional knockdown, single lab","pmids":["20378569"],"is_preprint":false},{"year":2011,"finding":"Noxa controls Mcl-1 ubiquitination and proteasomal degradation at the mitochondria by disrupting the USP9X/Mcl-1 interaction: Noxa overexpression decreases USP9X–Mcl-1 binding, increases Mcl-1 polyubiquitination, increases Mule–Mcl-1 interaction, and decreases Mule–USP9X complex, resulting in proteasomal Mcl-1 degradation. Noxa's degradative effect requires its exclusive mitochondrial localization.","method":"Co-immunoprecipitation, ubiquitination assay, subcellular fractionation, Noxa overexpression","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — reciprocal Co-IP and ubiquitination assay, single lab","pmids":["21907705"],"is_preprint":false},{"year":2011,"finding":"Full-length Noxa binds Mcl-1 with Kd ~3.4 nM, Bcl-xL with ~70 nM, and wild-type Bcl-2 with ~250 nM by surface plasmon resonance, demonstrating selectivity but not absolute specificity for Mcl-1; Noxa–Bcl-2 interaction is confirmed by co-pulldown from cells, and Bcl-2 overexpression reduces bortezomib-induced apoptosis.","method":"Surface plasmon resonance with recombinant proteins, co-immunoprecipitation, Bcl-2 overexpression/knockdown, apoptosis assays","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro binding kinetics with recombinant proteins plus cellular validation, multiple orthogonal methods","pmids":["21454712"],"is_preprint":false},{"year":2011,"finding":"Oncogenic H-Ras induces Noxa expression, and Noxa displaces Mcl-1 from Beclin-1, enabling Beclin-1-dependent autophagy and autophagic cell death; Noxa or Beclin-1 silencing reduces Ras-induced autophagy and increases clonogenic survival.","method":"siRNA knockdown, co-immunoprecipitation (Noxa–Mcl-1, Mcl-1–Beclin-1), autophagy assays, clonogenic survival","journal":"Molecular cell","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP showing complex disruption, siRNA epistasis, single lab","pmids":["21353614"],"is_preprint":false},{"year":2011,"finding":"In neuroblastoma cells, endogenous Noxa associates (by immunoprecipitation) with both Bcl-xL and Mcl-1; shRNA knockdown of Noxa significantly reduces bortezomib-induced apoptosis, while Bcl-xL (but not Mcl-1) overexpression prevents apoptosis, establishing that Noxa neutralizes Bcl-xL in neuronal cells.","method":"Co-immunoprecipitation, shRNA knockdown, overexpression of Bcl-xL vs Mcl-1, apoptosis assays","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP plus functional epistasis, single lab","pmids":["20051518"],"is_preprint":false},{"year":2010,"finding":"During T cell activation, Noxa is induced and acts as a competitive selector during immune responses: Pmaip1-/- effector T cells display decreased antigen affinity and persistence of subdominant clones; Mcl-1 protein stability is controlled by TCR affinity-dependent IL-2 signaling, defining a Noxa/Mcl-1 axis that enforces affinity-based selection.","method":"Pmaip1-/- mice, influenza infection model, TCR affinity measurement, IL-2 signaling analysis","journal":"Immunity","confidence":"High","confidence_rationale":"Tier 2 / Strong — in vivo genetic KO with mechanistic pathway identification, replicated across multiple antigens","pmids":["20620942"],"is_preprint":false},{"year":2014,"finding":"Noxa recruits MCL-1 from the cytosol to the mitochondria; Noxa mutations in the BH3 domain, C-terminal mitochondrial targeting domain, or ubiquitinated lysines alter both Noxa localization/stability and MCL-1 mitochondrial localization, phosphorylation, and ubiquitination, triggering proteasome-mediated MCL-1 degradation.","method":"Noxa mutant expression, subcellular fractionation, phosphorylation/ubiquitination analysis, MCL-1 stability assays","journal":"Cell death & disease","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — structure-function mutagenesis with functional readouts, single lab","pmids":["24525728"],"is_preprint":false},{"year":2014,"finding":"The C-terminal tail of Noxa contains a degron mediating ubiquitylation-independent proteasomal degradation; this degron does not require Mcl-1 interaction for Noxa degradation, but mutation of the C-terminal tail stabilizes both Noxa and endogenous Mcl-1 through BH3-mediated direct interaction.","method":"Noxa C-terminal deletion/mutation constructs, proteasome inhibition, co-immunoprecipitation, protein half-life assays","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro reconstitution-like mutagenesis identifying a defined degron sequence, ectopic placement of degron onto other proteins, single lab","pmids":["24811167"],"is_preprint":false},{"year":2010,"finding":"NF-κB is required for p53-mediated Noxa induction at the protein level (without affecting Noxa mRNA) and for p73-mediated induction of Noxa mRNA; in NF-κB-deficient MEFs, genotoxin treatment fails to induce p73 activation and Noxa mRNA, and cytochrome c release is compromised.","method":"p65-/- knockout MEFs, microarray, cytochrome c release assay, NF-κB inhibition","journal":"Cell cycle (Georgetown, Tex.) / Aging","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic KO with mechanistic follow-up, two papers from related labs","pmids":["20160496","20195489"],"is_preprint":false},{"year":2012,"finding":"miR-200c directly represses Noxa expression by binding a target site in the Noxa 3'UTR, as validated by luciferase reporter assay; miR-200c overexpression reduces basal and proteasome-inhibitor-induced Noxa levels.","method":"Luciferase reporter assay with 3'UTR, miR-200c overexpression, RT-PCR, Western blot","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — luciferase reporter validates direct binding site, single lab","pmids":["22615771"],"is_preprint":false},{"year":2014,"finding":"miR-23a negatively regulates NOXA by binding its 3'UTR; heat shock reduces miR-23a levels, leading to NOXA mRNA accumulation and apoptosis; HSP70 protects cells by maintaining miR-23a stability, thereby suppressing NOXA expression.","method":"RT-qPCR, stable miR-23a overexpression/knockdown, apoptosis assays, miR-23a stability measurement","journal":"Cell death & disease","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — gain/loss of miR-23a with functional apoptosis readout, single lab","pmids":["25429623"],"is_preprint":false},{"year":2014,"finding":"NOXA protein is degraded by autophagy: p62 acts as autophagic cargo receptor for NOXA, and three C-terminal lysine residues of NOXA are required for its lysosomal degradation; autophagy inhibition increases NOXA protein levels and promotes apoptosis.","method":"Autophagy inhibitors, p62 knockdown, NOXA lysine mutants, protein half-life assays, apoptosis assays","journal":"Biochimica et biophysica acta. Molecular cell research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — mutational mapping of lysine residues required for p62-mediated degradation, single lab","pmids":["29758299"],"is_preprint":false},{"year":2015,"finding":"Sall2 transcription factor directly binds conserved sites in the NOXA promoter (validated by EMSA and ChIP) and positively regulates Noxa expression; Sall2-/- MEFs show decreased Noxa induction and reduced apoptosis in response to doxorubicin even in the presence of functional p53.","method":"EMSA, ChIP, Sall2-/- MEFs, promoter-reporter assay, apoptosis assays","journal":"Cell death & disease","confidence":"Medium","confidence_rationale":"Tier 1–2 / Moderate — ChIP and EMSA validate direct binding, genetic KO epistasis, single lab","pmids":["26181197"],"is_preprint":false},{"year":2015,"finding":"MLN4924 (NAE inhibitor) causes c-Myc accumulation (as a CRL substrate), which transactivates the PMAIP1 gene encoding Noxa; c-Myc knockdown diminishes Noxa induction, and Noxa siRNA diminishes MLN4924-induced killing in AML; Noxa also neutralizes Mcl-1 to synergize with BCL2 inhibitors.","method":"siRNA knockdown of c-Myc and Noxa, Western blot, apoptosis assays, Bax/Bak activation","journal":"Cell death and differentiation","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — functional epistasis by siRNA, consistent with c-MYC mechanism from PMID:18042711, single lab","pmids":["26045051"],"is_preprint":false},{"year":2018,"finding":"ATF3 and ATF4 cooperatively bind the CRE element in the NOXA promoter and transcriptionally activate Noxa in a p53-independent manner; ERK1 is involved in cisplatin-induced ATF4 and Noxa induction; ATF3 or ATF4 knockdown reduces cisplatin-induced Noxa expression.","method":"Promoter-luciferase reporter assays, siRNA knockdown of ATF3/ATF4, Western blot, ChIP-like binding assays","journal":"Molecular oncology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — promoter reporter with CRE mutants plus siRNA epistasis, single lab","pmids":["29352505"],"is_preprint":false},{"year":2020,"finding":"MARCH5 (mitochondria-associated E3 ubiquitin ligase) is the primary mediator of NOXA-dependent MCL1 degradation in prostate cancer cells; MARCH5 loss prevents Noxa-driven MCL1 ubiquitination and degradation, and MARCH5 inhibition sensitizes cells to BCLXL-targeting BH3 mimetics.","method":"MARCH5 knockdown/inhibition, ubiquitination assays, apoptosis assays, MCL1 stability measurement","journal":"eLife","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic and pharmacological MARCH5 manipulation with mechanistic ubiquitination readouts, validated across multiple models, replicated by two independent papers (PMID:32015503, PMID:32094511)","pmids":["32484436"],"is_preprint":false},{"year":2020,"finding":"MARCH5 controls MCL1/NOXA complex levels during steady state and mitotic arrest; MARCH5 inhibition causes NOXA accumulation, sensitizes cancer cells to microtubule-targeting agents, and primes cells that undergo mitotic slippage to die in G1. The E2 enzyme UBE2K and mitochondrial outer membrane protein MTCH2 cooperate with MARCH5 to degrade MCL1 specifically when engaged by NOXA.","method":"Genome-wide CRISPR-Cas9 screen, MARCH5 inhibition, MCL1/NOXA co-IP, ubiquitination assays, mitotic arrest experiments","journal":"Cell death and differentiation / Cell death and differentiation","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — unbiased CRISPR screen identifying MARCH5/UBE2K/MTCH2, validated by Co-IP and ubiquitination, independently replicated in two simultaneous papers","pmids":["32015503","32094511"],"is_preprint":false},{"year":2021,"finding":"Cullin-5 (CUL5) neddylation-mediated ubiquitination is responsible for NOXA proteasomal degradation in colorectal cancer; PRDX1 oligomers promote this by bridging UBE2F and CUL5 to enhance CUL5 neddylation; PRDX1 silencing reduces CUL5 neddylation and extends NOXA protein half-life.","method":"Ubiquitination assays, neddylation inhibition, PRDX1 knockdown, Co-IP of UBE2F/CUL5/PRDX1 tricomplex, NOXA half-life measurement","journal":"Cell death & disease","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP identifying tricomplex, neddylation inhibition with functional readout, single lab","pmids":["33712558"],"is_preprint":false},{"year":2020,"finding":"5-Azacitidine induces NOXA transcription via the integrated stress response (ISR) pathway within hours, independent of DNA methylation; NOXA complexes with anti-apoptotic proteins to 'prime' AML cells for venetoclax-induced apoptosis; PMAIP1 CRISPR knockout abolishes venetoclax/5-Aza synergy.","method":"CRISPR-Cas9 PMAIP1 knockout, Western blot, qPCR, Co-IP, in vivo xenograft models","journal":"Clinical cancer research","confidence":"High","confidence_rationale":"Tier 2 / Strong — CRISPR KO as definitive loss-of-function, in vitro and in vivo validation, Co-IP of NOXA with anti-apoptotic partners","pmids":["32054729"],"is_preprint":false},{"year":2014,"finding":"Pemetrexed increases Noxa expression through ATF4 and ATF3 upregulation; Noxa upregulation reduces USP9X availability to Mcl-1, promoting Mcl-1 ubiquitination and degradation, leading to apoptosis (Noxa-Usp9x-Mcl-1 axis); Noxa siRNA promotes Usp9x expression.","method":"siRNA knockdown of Noxa/ATF4/ATF3/Usp9x, Western blot, Co-IP, apoptosis assays","journal":"Cell death & disease","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — siRNA epistasis and Co-IP defining Noxa-Usp9x-Mcl-1 axis, single lab","pmids":["24991768"],"is_preprint":false},{"year":2014,"finding":"NOXA mRNA is highly expressed but protein is rapidly degraded (T½ ~15–30 min) via ubiquitination and proteasomal degradation in mantle cell lymphoma cells; B-cell receptor signaling and cyclin D1 overexpression contribute to NOXA mRNA expression via PI3K/AKT/mTOR pathway.","method":"Protein half-life measurement, ubiquitination analysis, BCR signaling inhibitors, Western blot, mRNA analysis","journal":"Cell death & disease","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — protein turnover analysis with pathway inhibitors, single lab","pmids":["24457957"],"is_preprint":false},{"year":2013,"finding":"Noxa is phosphorylated at Ser13 by JNK in H. pylori-infected gastric epithelial cells, causing cytoplasmic retention of Noxa and impaired Mcl-1–Noxa interaction; JNK inhibition restores Mcl-1–Noxa interaction at mitochondria, and overexpression of non-phosphorylatable Noxa enhances mitochondrial apoptosis.","method":"In vitro binding assay, immunoprecipitation, confocal microscopy (subcellular localization), phospho-specific analysis, JNK inhibition, Noxa mutant expression","journal":"FASEB journal","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — phospho-mutant functional analysis with Co-IP and localization, single lab","pmids":["25404713"],"is_preprint":false},{"year":2012,"finding":"Myocardin-related transcription factor A (MAL/MRTF-A) directly transcriptionally induces Noxa/Pmaip1 expression via a CArG-like box in its promoter; MAL and SRF are recruited to the Noxa promoter upon G-actin-MAL-SRF pathway activation, and this is sensitive to latrunculin but p53-independent.","method":"ChIP, promoter-reporter assay with CArG-box mutants, latrunculin treatment, p53-depletion","journal":"Cell cycle (Georgetown, Tex.)","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP and promoter mutant validation, single lab","pmids":["22185759"],"is_preprint":false},{"year":2010,"finding":"Hydrogen peroxide induces Noxa protein accumulation via ATF4-dependent Noxa mRNA increase and simultaneous inhibition of Noxa protein degradation; Noxa silencing strongly suppresses H2O2-induced apoptosis, establishing Noxa as a crucial mediator of oxidative stress-induced mitochondrial apoptosis.","method":"siRNA knockdown, Western blot, mRNA analysis, Bcl-2 overexpression, Bax/Bak DKO cells","journal":"FEBS letters","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — siRNA knockdown with defined pathway (ATF4→Noxa mRNA + protein stabilization), single lab","pmids":["20085765"],"is_preprint":false},{"year":2021,"finding":"KLF4 transcription factor binds a specific UV-inducible CRE-like element in the NOXA promoter and mediates ERK-dependent, p53-independent NOXA transcriptional induction; KLF4 knockdown reduces NOXA expression in p53-mutated TNBC cells, and KLF4-inducing compound APTO-253 induces NOXA-mediated apoptosis.","method":"Promoter-reporter assay with defined element, KLF4 siRNA knockdown, ERK inhibition, APTO-253 compound treatment","journal":"Genes","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — promoter element mapping plus siRNA and pharmacological epistasis, single lab","pmids":["33918002"],"is_preprint":false},{"year":2016,"finding":"PHF8 histone demethylase promotes loss of repressive H3K9me2 mark from the PMAIP1 transcription start site and activates its transcription; PHF8 loss reduces apoptosis during early ESC differentiation; Pmaip1 knockdown mimics the PHF8-deficient phenotype (decreased apoptosis, promoted mesodermal/cardiac differentiation).","method":"PHF8 knockout, ChIP (H3K9me2 at PMAIP1 TSS), pmaip1 knockdown/overexpression, apoptosis and differentiation assays","journal":"Stem cells (Dayton, Ohio)","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP of histone mark at specific locus with genetic epistasis, single lab","pmids":["26866517"],"is_preprint":false},{"year":2022,"finding":"RUNX1 inhibition reshapes the epigenetic landscape at the NOXA promoter with H3K27ac enrichment, leading to NOXA upregulation and NOXA-dependent cell death in PDAC; NOXA expression in PDAC marks a subtype with synthetic lethality to RUNX1 inhibition.","method":"Genome-wide CRISPR drug screen, NOXA isogenic KO cell lines, ChIP-seq for H3K27ac, RUNX1 gain/loss-of-function, patient-derived organoids","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — unbiased screen with NOXA isogenic validation and ChIP-seq, single lab, patient-derived organoids","pmids":["35197278"],"is_preprint":false},{"year":2013,"finding":"During oxidative stress, lysosomal membrane permeabilization (LMP) acts upstream of MOMP; LMP induces p53-dependent Noxa expression, and Noxa expression is required for MOMP and subsequent apoptosis; MOMP but not LMP is Noxa-dependent.","method":"Noxa siRNA, iron chelation, LMP assays, MOMP assay, p53 pathway analysis","journal":"Free radical biology & medicine","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — siRNA and organelle stabilization establishing LMP→Noxa→MOMP order, single lab","pmids":["23770082"],"is_preprint":false},{"year":2008,"finding":"Noxa (along with Bmf and Bim) is induced by arsenic trioxide in myeloma and shown by co-immunoprecipitation to bind Mcl-1, displacing Bak and Bim; Noxa silencing significantly protects myeloma cells from ATO-induced apoptosis; Noxa induction is enhanced by GSH depletion and inhibited by GSH elevation.","method":"Gene expression profiling, co-immunoprecipitation, siRNA knockdown, GSH manipulation","journal":"Blood","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP plus siRNA epistasis, single lab","pmids":["18354037"],"is_preprint":false},{"year":2014,"finding":"Noxa upregulation in melanoma is driven by oncogenic BRAFV600E/MEK/ERK signaling via CREB transcription factor; Noxa promotes constitutive low-level autophagy via MEK/ERK and is required for autophagy-mediated delay of apoptosis under nutrient deprivation.","method":"BRAFV600E/MEK inhibitors, CREB reporter assay, Noxa siRNA, autophagy assays","journal":"Oncotarget","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple inhibitors with Noxa siRNA epistasis and CREB reporter, single lab","pmids":["25365078"],"is_preprint":false}],"current_model":"NOXA/PMAIP1 is a BH3-only proapoptotic Bcl-2 family protein that is transcriptionally induced by p53, p73, HIF-1α, c-MYC, ATF3/ATF4, ERK/CREB, KLF4, FKHRL1/FoxO3a, and MAL/MRTF-A in response to diverse stresses; it selectively binds and inactivates anti-apoptotic MCL-1 (and to a lesser extent Bcl-xL and Bcl-2), and upon binding recruits MCL-1 to the mitochondrial outer membrane where the E3 ligase MARCH5 (together with UBE2K and MTCH2) ubiquitinates and targets the MCL-1:NOXA complex for proteasomal degradation, thereby releasing BAK/BAX and BIM to trigger mitochondrial outer membrane permeabilization, cytochrome c release, and caspase-dependent apoptosis; NOXA itself is also a highly labile protein degraded by the proteasome (via a C-terminal degron and ubiquitination on multiple lysines, regulated by CUL5/Nedd8 and USP9X) and by autophagy (via p62), and its subcellular localization and function are modulated by JNK-mediated phosphorylation at Ser13; epigenetically, NOXA transcription is repressed by Bmi1-mediated H3K27 methylation and PHF8-regulated H3K9me2, and post-transcriptionally suppressed by miR-200c and miR-23a."},"narrative":{"mechanistic_narrative":"PMAIP1 (NOXA) is a stress-inducible BH3-only proapoptotic Bcl-2 family protein that couples diverse cellular stresses to mitochondrial outer membrane permeabilization (MOMP) and intrinsic apoptosis [PMID:12952892, PMID:14500851]. Genetic loss of Noxa in mice and MEFs blunts apoptosis triggered by DNA damage, UV irradiation, and oncogene-driven stress, placing it upstream of BAX/BAK in the intrinsic pathway, with cell-type-specific dominance over PUMA in fibroblasts and transformed cells [PMID:12952892, PMID:14500851, PMID:17283183, PMID:17024184]. NOXA acts by selectively binding the labile anti-apoptotic protein MCL-1, with high affinity (Kd ~3.4 nM) and lower affinity for Bcl-xL and Bcl-2 [PMID:21454712]; this engagement displaces BAK and BIM from MCL-1 to license BAX/BAK activation, cytochrome c release, and caspase activation [PMID:16782027, PMID:17545623]. Beyond sequestration, NOXA recruits cytosolic MCL-1 to mitochondria and drives its destruction: the mitochondria-associated E3 ligase MARCH5, cooperating with the E2 UBE2K and the outer-membrane protein MTCH2, ubiquitinates MCL-1 specifically when it is engaged by NOXA, targeting the complex for proteasomal degradation [PMID:32484436, PMID:32015503, PMID:32094511], a process reinforced by NOXA-dependent disruption of the USP9X–MCL-1 deubiquitinating interaction [PMID:21907705, PMID:24991768]. NOXA transcription integrates a broad range of signals through p53 [PMID:12952892], p73 [PMID:15572378], HIF-1α [PMID:14699081], c-MYC [PMID:18042711, PMID:26045051], FoxO3a/FKHRL1 [PMID:16888645], the ATF3/ATF4 integrated stress response [PMID:29352505, PMID:20085765], ERK/CREB and KLF4 [PMID:20802529, PMID:33918002, PMID:25365078], and the MAL/MRTF-A–SRF axis [PMID:22185759], while being epigenetically repressed by Bmi1-directed H3K27 methylation and PHF8-regulated H3K9me2 [PMID:18411339, PMID:26866517]. NOXA protein is itself highly labile, degraded by the proteasome via a C-terminal degron and multi-lysine ubiquitination under CUL5/neddylation control [PMID:20378569, PMID:24811167, PMID:33712558], and cleared by p62-dependent autophagy [PMID:29758299]; JNK phosphorylation at Ser13 retains it in the cytoplasm and impairs MCL-1 binding [PMID:25404713]. NOXA also extends beyond apoptosis to autophagy regulation, displacing MCL-1 from Beclin-1 to enable autophagic responses [PMID:21353614], and serves a physiological role in affinity-based selection of effector T cells [PMID:20620942].","teleology":[{"year":2003,"claim":"Established NOXA as a p53-inducible BH3-only effector genetically required for intrinsic apoptosis, defining its place upstream of BAX in stress-induced cell death.","evidence":"Noxa-/- knockout mice and MEFs with DNA-damage and irradiation apoptosis assays, replicated across two labs with cell-type resolution","pmids":["12952892","14500851"],"confidence":"High","gaps":["Did not define the molecular target NOXA engages to trigger MOMP","Cell-type-specific dependence (fibroblasts vs lymphocytes) left mechanistically unexplained"]},{"year":2003,"claim":"Showed NOXA induction is not exclusively p53-driven, linking hypoxia to NOXA-dependent death and extending its relevance to ischemic injury.","evidence":"HIF-1α promoter reporter assays, antisense knockdown, and in vivo ischemia/infarction model","pmids":["14699081"],"confidence":"Medium","gaps":["Direct HIF-1α occupancy not confirmed by ChIP","Single lab"]},{"year":2006,"claim":"Identified MCL-1 as NOXA's key binding partner and framed the NOXA/MCL-1 ratio as an apoptotic rheostat in metabolically stressed cells.","evidence":"Co-immunoprecipitation plus reciprocal siRNA epistasis under glucose deprivation in T cells","pmids":["16782027"],"confidence":"High","gaps":["Binding affinity and selectivity not quantified","Mechanism downstream of MCL-1 neutralization not yet resolved"]},{"year":2007,"claim":"Demonstrated that NOXA neutralizes MCL-1 by competitive displacement, freeing BAK and BIM to activate the executioner machinery.","evidence":"Reciprocal Co-IP showing MCL-1/NOXA complex formation and BIM/BAK displacement in bortezomib-treated myeloma","pmids":["17545623"],"confidence":"High","gaps":["Did not establish whether MCL-1 is degraded or only sequestered","Contribution of MCL-1 cleavage unresolved"]},{"year":2011,"claim":"Quantified NOXA's binding selectivity, showing strong but non-absolute preference for MCL-1 over Bcl-xL and Bcl-2.","evidence":"Surface plasmon resonance with recombinant proteins plus cellular co-pulldown and apoptosis assays","pmids":["21454712"],"confidence":"High","gaps":["Cellular consequences of weaker Bcl-2/Bcl-xL binding context-dependent","Did not resolve in vivo target hierarchy"]},{"year":2011,"claim":"Revealed that NOXA actively promotes MCL-1 degradation, not just sequestration, by disrupting the USP9X–MCL-1 deubiquitinase interaction at mitochondria.","evidence":"Reciprocal Co-IP, ubiquitination assays, and subcellular fractionation with NOXA overexpression","pmids":["21907705"],"confidence":"Medium","gaps":["E3 ligase responsible not yet identified","Single lab"]},{"year":2014,"claim":"Established that NOXA recruits cytosolic MCL-1 to mitochondria and that NOXA's degron and ubiquitinated lysines couple NOXA stability to MCL-1 turnover.","evidence":"Structure-function mutagenesis of NOXA BH3, C-terminal targeting domain, and lysines with MCL-1 stability readouts; C-terminal degron transfer experiments","pmids":["24525728","24811167"],"confidence":"High","gaps":["Mitochondrial E3 ligase for the recruited complex still unidentified","Relative roles of ubiquitin-dependent vs degron-mediated turnover incompletely separated"]},{"year":2020,"claim":"Identified MARCH5 (with UBE2K and MTCH2) as the E3 machinery that ubiquitinates MCL-1 specifically when engaged by NOXA, completing the NOXA→MCL-1 degradation circuit.","evidence":"Genome-wide CRISPR screen, MARCH5 genetic/pharmacological manipulation, MCL1/NOXA Co-IP and ubiquitination assays, replicated across three simultaneous papers","pmids":["32484436","32015503","32094511"],"confidence":"High","gaps":["Structural basis for NOXA-dependent substrate recognition by MARCH5 not defined","Tissue-specific dependence on this axis unclear"]},{"year":2018,"claim":"Mapped a broad p53-independent transcriptional network (c-MYC, p73, FoxO3a, ATF3/ATF4, ERK/CREB, KLF4, MAL/MRTF-A) that funnels diverse stresses into NOXA induction.","evidence":"ChIP, promoter-reporter assays with element mutants, and gain/loss-of-function across multiple stress and cancer contexts","pmids":["18042711","15572378","16888645","29352505","33918002","22185759","26045051"],"confidence":"High","gaps":["Combinatorial logic among these factors at the promoter not resolved","Most validations from single labs in specific cell types"]},{"year":2021,"claim":"Defined multilayered control of NOXA abundance through proteasomal degradation (CUL5/neddylation, multi-lysine ubiquitination, C-terminal degron), p62-mediated autophagy, JNK Ser13 phosphorylation, and microRNA repression.","evidence":"Ubiquitination and half-life assays, neddylation inhibition, lysine/degron mutants, phospho-mutant localization studies, and 3'UTR luciferase reporters","pmids":["20378569","33712558","24811167","24524772","29758299","25404713","22615771","25429623"],"confidence":"Medium","gaps":["Relative quantitative contribution of proteasomal vs autophagic clearance unclear","How phosphorylation, ubiquitination, and degron use are coordinated unresolved"]},{"year":2010,"claim":"Extended NOXA function beyond apoptosis to physiological T-cell affinity selection and to autophagy regulation via MCL-1/Beclin-1 disruption.","evidence":"Pmaip1-/- mice in influenza infection with TCR affinity analysis; Co-IP and siRNA epistasis linking NOXA to Beclin-1-dependent autophagy","pmids":["20620942","21353614"],"confidence":"High","gaps":["Molecular switch between pro-apoptotic and pro-autophagic NOXA outputs undefined","Physiological non-immune roles of NOXA largely uncharacterized"]},{"year":null,"claim":"How NOXA's binding partner choice, subcellular localization, post-translational state, and degradation route are integrated to dictate apoptosis versus autophagy versus survival outcomes remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No structural model of the NOXA–MCL-1–MARCH5 substrate complex","Quantitative thresholds governing rheostat behavior in vivo not established","Integration of phosphorylation and degradation inputs into functional output undefined"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[4,6,15,17,41]},{"term_id":"GO:0140313","term_label":"molecular sequestering activity","supporting_discovery_ids":[4,6,16]}],"localization":[{"term_id":"GO:0005739","term_label":"mitochondrion","supporting_discovery_ids":[14,19,34]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[19,34]}],"pathway":[{"term_id":"R-HSA-5357801","term_label":"Programmed Cell Death","supporting_discovery_ids":[0,1,6,9]},{"term_id":"R-HSA-8953897","term_label":"Cellular responses to stimuli","supporting_discovery_ids":[2,27,36]},{"term_id":"R-HSA-9612973","term_label":"Autophagy","supporting_discovery_ids":[16,24,42]}],"complexes":[],"partners":["MCL1","BCL2L1","BCL2","USP9X","MARCH5","BECN1","BIM"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q13794","full_name":"Phorbol-12-myristate-13-acetate-induced protein 1","aliases":["Immediate-early-response protein APR","Protein Noxa"],"length_aa":54,"mass_kda":6.0,"function":"Promotes activation of caspases and apoptosis. Promotes mitochondrial membrane changes and efflux of apoptogenic proteins from the mitochondria. Contributes to p53/TP53-dependent apoptosis after radiation exposure. Promotes proteasomal degradation of MCL1. Competes with BAK1 for binding to MCL1 and can displace BAK1 from its binding site on MCL1 (By similarity). Competes with BIM/BCL2L11 for binding to MCL1 and can displace BIM/BCL2L11 from its binding site on MCL1","subcellular_location":"Mitochondrion","url":"https://www.uniprot.org/uniprotkb/Q13794/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/PMAIP1","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1207,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/PMAIP1","total_profiled":1310},"omim":[{"mim_id":"620976","title":"ZINC FINGER PROTEIN 740; ZNF740","url":"https://www.omim.org/entry/620976"},{"mim_id":"620311","title":"PREMATURE OVARIAN FAILURE 21; POF21","url":"https://www.omim.org/entry/620311"},{"mim_id":"618617","title":"ZINC FINGER HIT DOMAIN-CONTAINING PROTEIN 1; ZNHIT1","url":"https://www.omim.org/entry/618617"},{"mim_id":"617700","title":"UBIQUITIN-CONJUGATING ENZYME E2 F; UBE2F","url":"https://www.omim.org/entry/617700"},{"mim_id":"607218","title":"INTERFERON REGULATORY FACTOR 5; IRF5","url":"https://www.omim.org/entry/607218"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Uncertain","locations":[{"location":"Vesicles","reliability":"Uncertain"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"bone marrow","ntpm":83.2}],"url":"https://www.proteinatlas.org/search/PMAIP1"},"hgnc":{"alias_symbol":["APR","NOXA"],"prev_symbol":[]},"alphafold":{"accession":"Q13794","domains":[],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q13794","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q13794-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q13794-F1-predicted_aligned_error_v6.png","plddt_mean":81.94},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=PMAIP1","jax_strain_url":"https://www.jax.org/strain/search?query=PMAIP1"},"sequence":{"accession":"Q13794","fasta_url":"https://rest.uniprot.org/uniprotkb/Q13794.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q13794/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q13794"}},"corpus_meta":[{"pmid":"14500851","id":"PMC_14500851","title":"p53- and drug-induced apoptotic responses mediated by BH3-only proteins puma and noxa.","date":"2003","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/14500851","citation_count":1090,"is_preprint":false},{"pmid":"21353614","id":"PMC_21353614","title":"Oncogenic Ras-induced expression of Noxa and Beclin-1 promotes autophagic cell death and limits clonogenic survival.","date":"2011","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/21353614","citation_count":350,"is_preprint":false},{"pmid":"12952892","id":"PMC_12952892","title":"Integral role of Noxa in p53-mediated apoptotic response.","date":"2003","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/12952892","citation_count":285,"is_preprint":false},{"pmid":"16024630","id":"PMC_16024630","title":"Proteasome inhibitors trigger NOXA-mediated apoptosis in melanoma and myeloma cells.","date":"2005","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/16024630","citation_count":275,"is_preprint":false},{"pmid":"19641509","id":"PMC_19641509","title":"Noxa: at the tip of the balance between life and death.","date":"2008","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/19641509","citation_count":234,"is_preprint":false},{"pmid":"14699081","id":"PMC_14699081","title":"BH3-only protein Noxa is a mediator of hypoxic cell death induced by hypoxia-inducible factor 1alpha.","date":"2003","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/14699081","citation_count":234,"is_preprint":false},{"pmid":"17545623","id":"PMC_17545623","title":"Noxa up-regulation and Mcl-1 cleavage are associated to apoptosis induction by bortezomib in multiple myeloma.","date":"2007","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/17545623","citation_count":212,"is_preprint":false},{"pmid":"32054729","id":"PMC_32054729","title":"5-Azacitidine Induces NOXA to Prime AML Cells for Venetoclax-Mediated Apoptosis.","date":"2020","source":"Clinical cancer research : an official journal of the American Association for Cancer Research","url":"https://pubmed.ncbi.nlm.nih.gov/32054729","citation_count":163,"is_preprint":false},{"pmid":"16782027","id":"PMC_16782027","title":"The Noxa/Mcl-1 axis regulates susceptibility to apoptosis under glucose limitation in dividing T cells.","date":"2006","source":"Immunity","url":"https://pubmed.ncbi.nlm.nih.gov/16782027","citation_count":157,"is_preprint":false},{"pmid":"18042711","id":"PMC_18042711","title":"Tumor cell-selective regulation of NOXA by c-MYC in response to proteasome inhibition.","date":"2007","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/18042711","citation_count":150,"is_preprint":false},{"pmid":"16888645","id":"PMC_16888645","title":"FKHRL1-mediated expression of Noxa and Bim induces apoptosis via the mitochondria in neuroblastoma cells.","date":"2006","source":"Cell death and differentiation","url":"https://pubmed.ncbi.nlm.nih.gov/16888645","citation_count":142,"is_preprint":false},{"pmid":"30660647","id":"PMC_30660647","title":"Cannabidiol-induced apoptosis is mediated by activation of Noxa in human colorectal cancer cells.","date":"2019","source":"Cancer letters","url":"https://pubmed.ncbi.nlm.nih.gov/30660647","citation_count":131,"is_preprint":false},{"pmid":"15102863","id":"PMC_15102863","title":"BOK and NOXA are essential mediators of p53-dependent apoptosis.","date":"2004","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15102863","citation_count":123,"is_preprint":false},{"pmid":"22173547","id":"PMC_22173547","title":"Modulation of NOXA and MCL-1 as a strategy for sensitizing melanoma cells to the BH3-mimetic ABT-737.","date":"2011","source":"Clinical cancer research : an official journal of the American Association for Cancer Research","url":"https://pubmed.ncbi.nlm.nih.gov/22173547","citation_count":95,"is_preprint":false},{"pmid":"17283183","id":"PMC_17283183","title":"Ultraviolet radiation triggers apoptosis of fibroblasts and skin keratinocytes mainly via the BH3-only protein Noxa.","date":"2007","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/17283183","citation_count":93,"is_preprint":false},{"pmid":"18411339","id":"PMC_18411339","title":"Bmi1 regulates memory CD4 T cell survival via repression of the Noxa gene.","date":"2008","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/18411339","citation_count":88,"is_preprint":false},{"pmid":"24387758","id":"PMC_24387758","title":"Parthenolide induces apoptosis via TNFRSF10B and PMAIP1 pathways in human lung cancer cells.","date":"2014","source":"Journal of experimental & clinical cancer research : CR","url":"https://pubmed.ncbi.nlm.nih.gov/24387758","citation_count":87,"is_preprint":false},{"pmid":"21911456","id":"PMC_21911456","title":"2-deoxyglucose induces Noxa-dependent apoptosis in alveolar rhabdomyosarcoma.","date":"2011","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/21911456","citation_count":83,"is_preprint":false},{"pmid":"17024184","id":"PMC_17024184","title":"Differential contribution of Puma and Noxa in dual regulation of p53-mediated apoptotic pathways.","date":"2006","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/17024184","citation_count":83,"is_preprint":false},{"pmid":"23014529","id":"PMC_23014529","title":"TRAIL and Noxa are selectively upregulated in prostate cancer cells downstream of the RIG-I/MAVS signaling pathway by nonreplicating Sendai virus particles.","date":"2012","source":"Clinical cancer research : an official journal of the American Association for Cancer Research","url":"https://pubmed.ncbi.nlm.nih.gov/23014529","citation_count":83,"is_preprint":false},{"pmid":"21907705","id":"PMC_21907705","title":"Noxa controls Mule-dependent Mcl-1 ubiquitination through the regulation of the Mcl-1/USP9X interaction.","date":"2011","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/21907705","citation_count":83,"is_preprint":false},{"pmid":"26045051","id":"PMC_26045051","title":"MLN4924 induces Noxa upregulation in acute myelogenous leukemia and synergizes with Bcl-2 inhibitors.","date":"2015","source":"Cell death and differentiation","url":"https://pubmed.ncbi.nlm.nih.gov/26045051","citation_count":82,"is_preprint":false},{"pmid":"20620942","id":"PMC_20620942","title":"Apoptosis threshold set by Noxa and Mcl-1 after T cell activation regulates competitive selection of high-affinity clones.","date":"2010","source":"Immunity","url":"https://pubmed.ncbi.nlm.nih.gov/20620942","citation_count":81,"is_preprint":false},{"pmid":"34193827","id":"PMC_34193827","title":"Puma, noxa, p53, and p63 differentially mediate stress pathway induced apoptosis.","date":"2021","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/34193827","citation_count":79,"is_preprint":false},{"pmid":"21454712","id":"PMC_21454712","title":"Noxa/Bcl-2 protein interactions contribute to bortezomib resistance in human lymphoid cells.","date":"2011","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/21454712","citation_count":79,"is_preprint":false},{"pmid":"20802529","id":"PMC_20802529","title":"An ERK-dependent pathway to Noxa expression regulates apoptosis by platinum-based chemotherapeutic drugs.","date":"2010","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/20802529","citation_count":73,"is_preprint":false},{"pmid":"20378569","id":"PMC_20378569","title":"Role of NOXA and its ubiquitination in proteasome inhibitor-induced apoptosis in chronic lymphocytic leukemia cells.","date":"2010","source":"Haematologica","url":"https://pubmed.ncbi.nlm.nih.gov/20378569","citation_count":73,"is_preprint":false},{"pmid":"28670929","id":"PMC_28670929","title":"Exploiting the pro-apoptotic function of NOXA as a therapeutic modality in cancer.","date":"2017","source":"Expert opinion on therapeutic targets","url":"https://pubmed.ncbi.nlm.nih.gov/28670929","citation_count":72,"is_preprint":false},{"pmid":"15572378","id":"PMC_15572378","title":"E1A activates transcription of p73 and Noxa to induce apoptosis.","date":"2004","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15572378","citation_count":72,"is_preprint":false},{"pmid":"35207544","id":"PMC_35207544","title":"BH3-Only Proteins Noxa and Puma Are Key Regulators of Induced Apoptosis.","date":"2022","source":"Life (Basel, Switzerland)","url":"https://pubmed.ncbi.nlm.nih.gov/35207544","citation_count":68,"is_preprint":false},{"pmid":"24525728","id":"PMC_24525728","title":"Noxa determines localization and stability of MCL-1 and consequently ABT-737 sensitivity in small cell lung cancer.","date":"2014","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/24525728","citation_count":67,"is_preprint":false},{"pmid":"23175245","id":"PMC_23175245","title":"A review of the role of Puma, Noxa and Bim in the tumorigenesis, therapy and drug resistance of chronic lymphocytic leukemia.","date":"2012","source":"Cancer gene therapy","url":"https://pubmed.ncbi.nlm.nih.gov/23175245","citation_count":66,"is_preprint":false},{"pmid":"24991768","id":"PMC_24991768","title":"Usp9x- and Noxa-mediated Mcl-1 downregulation contributes to pemetrexed-induced apoptosis in human non-small-cell lung cancer cells.","date":"2014","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/24991768","citation_count":65,"is_preprint":false},{"pmid":"18354037","id":"PMC_18354037","title":"BH3-only proteins Noxa, Bmf, and Bim are necessary for arsenic trioxide-induced cell death in myeloma.","date":"2008","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/18354037","citation_count":65,"is_preprint":false},{"pmid":"20051518","id":"PMC_20051518","title":"The anti-apoptotic protein BCL2L1/Bcl-xL is neutralized by pro-apoptotic PMAIP1/Noxa in neuroblastoma, thereby determining bortezomib sensitivity independent of prosurvival MCL1 expression.","date":"2010","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/20051518","citation_count":63,"is_preprint":false},{"pmid":"29352505","id":"PMC_29352505","title":"p53-independent Noxa induction by cisplatin is regulated by ATF3/ATF4 in head and neck squamous cell carcinoma cells.","date":"2018","source":"Molecular oncology","url":"https://pubmed.ncbi.nlm.nih.gov/29352505","citation_count":56,"is_preprint":false},{"pmid":"19246337","id":"PMC_19246337","title":"ABT-737 synergizes with chemotherapy to kill head and neck squamous cell carcinoma cells via a Noxa-mediated pathway.","date":"2009","source":"Molecular pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/19246337","citation_count":55,"is_preprint":false},{"pmid":"35370290","id":"PMC_35370290","title":"Identification of NOXA as a pivotal regulator of resistance to CAR T-cell therapy in B-cell malignancies.","date":"2022","source":"Signal transduction and targeted therapy","url":"https://pubmed.ncbi.nlm.nih.gov/35370290","citation_count":53,"is_preprint":false},{"pmid":"16822983","id":"PMC_16822983","title":"BH3-only proapoptotic Bcl-2 family members Noxa and Puma mediate neural precursor cell death.","date":"2006","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/16822983","citation_count":53,"is_preprint":false},{"pmid":"29521234","id":"PMC_29521234","title":"Noxa: Role in Cancer Pathogenesis and Treatment.","date":"2018","source":"Current cancer drug targets","url":"https://pubmed.ncbi.nlm.nih.gov/29521234","citation_count":50,"is_preprint":false},{"pmid":"16363061","id":"PMC_16363061","title":"Notch and NOXA-related pathways in melanoma cells.","date":"2005","source":"The journal of investigative dermatology. Symposium proceedings","url":"https://pubmed.ncbi.nlm.nih.gov/16363061","citation_count":50,"is_preprint":false},{"pmid":"32484436","id":"PMC_32484436","title":"MARCH5 mediates NOXA-dependent MCL1 degradation driven by kinase inhibitors and integrated stress response activation.","date":"2020","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/32484436","citation_count":49,"is_preprint":false},{"pmid":"29670053","id":"PMC_29670053","title":"Testosterone-Dependent miR-26a-5p and let-7g-5p Act as Signaling Mediators to Regulate Sperm Apoptosis via Targeting PTEN and PMAIP1.","date":"2018","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/29670053","citation_count":48,"is_preprint":false},{"pmid":"31296259","id":"PMC_31296259","title":"TFAP2C increases cell proliferation by downregulating GADD45B and PMAIP1 in non-small cell lung cancer cells.","date":"2019","source":"Biological research","url":"https://pubmed.ncbi.nlm.nih.gov/31296259","citation_count":47,"is_preprint":false},{"pmid":"17216584","id":"PMC_17216584","title":"Role of Noxa in p53-independent fenretinide-induced apoptosis of neuroectodermal tumours.","date":"2007","source":"Apoptosis : an international journal on programmed cell death","url":"https://pubmed.ncbi.nlm.nih.gov/17216584","citation_count":46,"is_preprint":false},{"pmid":"24457957","id":"PMC_24457957","title":"Discrepant NOXA (PMAIP1) transcript and NOXA protein levels: a potential Achilles' heel in mantle cell lymphoma.","date":"2014","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/24457957","citation_count":45,"is_preprint":false},{"pmid":"30404918","id":"PMC_30404918","title":"NOXA genetic amplification or pharmacologic induction primes lymphoma cells to BCL2 inhibitor-induced cell death.","date":"2018","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/30404918","citation_count":43,"is_preprint":false},{"pmid":"32854039","id":"PMC_32854039","title":"Gambogenic acid induces Noxa-mediated apoptosis in colorectal cancer through ROS-dependent activation of IRE1α/JNK.","date":"2020","source":"Phytomedicine : international journal of phytotherapy and phytopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/32854039","citation_count":42,"is_preprint":false},{"pmid":"20935673","id":"PMC_20935673","title":"ROS-mediated upregulation of Noxa overcomes chemoresistance in chronic lymphocytic leukemia.","date":"2010","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/20935673","citation_count":42,"is_preprint":false},{"pmid":"27308315","id":"PMC_27308315","title":"Noxa and cancer therapy: Tuning up the mitochondrial death machinery in response to chemotherapy.","date":"2014","source":"Molecular & cellular oncology","url":"https://pubmed.ncbi.nlm.nih.gov/27308315","citation_count":41,"is_preprint":false},{"pmid":"33310890","id":"PMC_33310890","title":"Proteasome Inhibition Overcomes ALK-TKI Resistance in ALK-Rearranged/TP53-Mutant NSCLC via Noxa Expression.","date":"2020","source":"Clinical cancer research : an official journal of the American Association for Cancer Research","url":"https://pubmed.ncbi.nlm.nih.gov/33310890","citation_count":40,"is_preprint":false},{"pmid":"32015503","id":"PMC_32015503","title":"MARCH5-dependent degradation of MCL1/NOXA complexes defines susceptibility to antimitotic drug treatment.","date":"2020","source":"Cell death and differentiation","url":"https://pubmed.ncbi.nlm.nih.gov/32015503","citation_count":40,"is_preprint":false},{"pmid":"33712558","id":"PMC_33712558","title":"Cullin-5 neddylation-mediated NOXA degradation is enhanced by PRDX1 oligomers in colorectal cancer.","date":"2021","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/33712558","citation_count":39,"is_preprint":false},{"pmid":"24811167","id":"PMC_24811167","title":"The carboxyl-terminal tail of Noxa protein regulates the stability of Noxa and Mcl-1.","date":"2014","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/24811167","citation_count":39,"is_preprint":false},{"pmid":"25365078","id":"PMC_25365078","title":"Noxa upregulation by oncogenic activation of MEK/ERK through CREB promotes autophagy in human melanoma cells.","date":"2014","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/25365078","citation_count":37,"is_preprint":false},{"pmid":"32094511","id":"PMC_32094511","title":"MARCH5 requires MTCH2 to coordinate proteasomal turnover of the MCL1:NOXA complex.","date":"2020","source":"Cell death and differentiation","url":"https://pubmed.ncbi.nlm.nih.gov/32094511","citation_count":36,"is_preprint":false},{"pmid":"20160496","id":"PMC_20160496","title":"p53-mediated induction of Noxa and p53AIP1 requires NFkappaB.","date":"2010","source":"Cell cycle (Georgetown, Tex.)","url":"https://pubmed.ncbi.nlm.nih.gov/20160496","citation_count":35,"is_preprint":false},{"pmid":"32424251","id":"PMC_32424251","title":"Bim, Puma and Noxa upregulation by Naftopidil sensitizes ovarian cancer to the BH3-mimetic ABT-737 and the MEK inhibitor Trametinib.","date":"2020","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/32424251","citation_count":35,"is_preprint":false},{"pmid":"33853293","id":"PMC_33853293","title":"Pevonedistat and azacitidine upregulate NOXA (PMAIP1) to increase sensitivity to venetoclax in preclinical models of acute myeloid leukemia.","date":"2022","source":"Haematologica","url":"https://pubmed.ncbi.nlm.nih.gov/33853293","citation_count":34,"is_preprint":false},{"pmid":"23770082","id":"PMC_23770082","title":"Noxa couples lysosomal membrane permeabilization and apoptosis during oxidative stress.","date":"2013","source":"Free radical biology & medicine","url":"https://pubmed.ncbi.nlm.nih.gov/23770082","citation_count":34,"is_preprint":false},{"pmid":"20195489","id":"PMC_20195489","title":"Activation of p73 and induction of Noxa by DNA damage requires NF-kappa B.","date":"2009","source":"Aging","url":"https://pubmed.ncbi.nlm.nih.gov/20195489","citation_count":33,"is_preprint":false},{"pmid":"19237507","id":"PMC_19237507","title":"Proapoptotic Noxa is required for particulate matter-induced cell death and lung inflammation.","date":"2009","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/19237507","citation_count":32,"is_preprint":false},{"pmid":"18056181","id":"PMC_18056181","title":"NOXA and PUMA expression add to clinical markers in predicting biochemical recurrence of prostate cancer patients in a survival tree model.","date":"2007","source":"Clinical cancer research : an official journal of the American Association for Cancer Research","url":"https://pubmed.ncbi.nlm.nih.gov/18056181","citation_count":31,"is_preprint":false},{"pmid":"22144184","id":"PMC_22144184","title":"BH3-only protein Noxa regulates apoptosis in activated B cells and controls high-affinity antibody formation.","date":"2011","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/22144184","citation_count":31,"is_preprint":false},{"pmid":"30255595","id":"PMC_30255595","title":"Repression of Noxa by Bmi1 contributes to deguelin-induced apoptosis in non-small cell lung cancer cells.","date":"2018","source":"Journal of cellular and molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/30255595","citation_count":30,"is_preprint":false},{"pmid":"35197278","id":"PMC_35197278","title":"NOXA expression drives synthetic lethality to RUNX1 inhibition in pancreatic cancer.","date":"2022","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/35197278","citation_count":29,"is_preprint":false},{"pmid":"22843330","id":"PMC_22843330","title":"D-Penicillamine targets metastatic melanoma cells with induction of the unfolded protein response (UPR) and Noxa (PMAIP1)-dependent mitochondrial apoptosis.","date":"2012","source":"Apoptosis : an international journal on programmed cell death","url":"https://pubmed.ncbi.nlm.nih.gov/22843330","citation_count":28,"is_preprint":false},{"pmid":"30182448","id":"PMC_30182448","title":"Targeting the overexpressed USP7 inhibits esophageal squamous cell carcinoma cell growth by inducing NOXA-mediated apoptosis.","date":"2018","source":"Molecular carcinogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/30182448","citation_count":27,"is_preprint":false},{"pmid":"31342239","id":"PMC_31342239","title":"Deubiquitylatinase inhibitor b-AP15 induces c-Myc-Noxa-mediated apoptosis in esophageal squamous cell carcinoma.","date":"2019","source":"Apoptosis : an international journal on programmed cell death","url":"https://pubmed.ncbi.nlm.nih.gov/31342239","citation_count":27,"is_preprint":false},{"pmid":"36265256","id":"PMC_36265256","title":"Evodiamine inhibits ESCC by inducing M-phase cell-cycle arrest via CUL4A/p53/p21 axis and activating noxa-dependent intrinsic and DR4-dependent extrinsic apoptosis.","date":"2022","source":"Phytomedicine : international journal of phytotherapy and phytopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/36265256","citation_count":27,"is_preprint":false},{"pmid":"30341788","id":"PMC_30341788","title":"The Nedd8-activating enzyme inhibitor MLN4924 (TAK-924/Pevonedistat) induces apoptosis via c-Myc-Noxa axis in head and neck squamous cell carcinoma.","date":"2018","source":"Cell proliferation","url":"https://pubmed.ncbi.nlm.nih.gov/30341788","citation_count":27,"is_preprint":false},{"pmid":"25404713","id":"PMC_25404713","title":"Regulation of Noxa-mediated apoptosis in Helicobacter pylori-infected gastric epithelial cells.","date":"2014","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/25404713","citation_count":26,"is_preprint":false},{"pmid":"22615771","id":"PMC_22615771","title":"MiR-200c regulates Noxa expression and sensitivity to proteasomal inhibitors.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/22615771","citation_count":26,"is_preprint":false},{"pmid":"34599296","id":"PMC_34599296","title":"APR-246 induces apoptosis and enhances chemo-sensitivity via activation of ROS and TAp73-Noxa signal in oesophageal squamous cell cancer with TP53 missense mutation.","date":"2021","source":"British journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/34599296","citation_count":26,"is_preprint":false},{"pmid":"23723123","id":"PMC_23723123","title":"Vinblastine rapidly induces NOXA and acutely sensitizes primary chronic lymphocytic leukemia cells to ABT-737.","date":"2013","source":"Molecular cancer therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/23723123","citation_count":26,"is_preprint":false},{"pmid":"24608793","id":"PMC_24608793","title":"Zebrafish Noxa promotes mitosis in early embryonic development and regulates apoptosis in subsequent embryogenesis.","date":"2014","source":"Cell death and differentiation","url":"https://pubmed.ncbi.nlm.nih.gov/24608793","citation_count":25,"is_preprint":false},{"pmid":"25429623","id":"PMC_25429623","title":"The elimination of miR-23a in heat-stressed cells promotes NOXA-induced cell death and is prevented by HSP70.","date":"2014","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/25429623","citation_count":25,"is_preprint":false},{"pmid":"28892004","id":"PMC_28892004","title":"Arenobufagin Induces Apoptotic Cell Death in Human Non-Small-Cell Lung Cancer Cells via the Noxa-Related Pathway.","date":"2017","source":"Molecules (Basel, Switzerland)","url":"https://pubmed.ncbi.nlm.nih.gov/28892004","citation_count":24,"is_preprint":false},{"pmid":"33918002","id":"PMC_33918002","title":"Krüppel-Like Factor 4 and Its Activator APTO-253 Induce NOXA-Mediated, p53-Independent Apoptosis in Triple-Negative Breast Cancer Cells.","date":"2021","source":"Genes","url":"https://pubmed.ncbi.nlm.nih.gov/33918002","citation_count":24,"is_preprint":false},{"pmid":"29758299","id":"PMC_29758299","title":"Autophagy regulates apoptosis by targeting NOXA for degradation.","date":"2018","source":"Biochimica et biophysica acta. Molecular cell research","url":"https://pubmed.ncbi.nlm.nih.gov/29758299","citation_count":23,"is_preprint":false},{"pmid":"35443722","id":"PMC_35443722","title":"Artesunate improves venetoclax plus cytarabine AML cell targeting by regulating the Noxa/Bim/Mcl-1/p-Chk1 axis.","date":"2022","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/35443722","citation_count":23,"is_preprint":false},{"pmid":"19421859","id":"PMC_19421859","title":"Repression of the BH3-only molecule PMAIP1/Noxa impairs glucocorticoid sensitivity of acute lymphoblastic leukemia cells.","date":"2009","source":"Apoptosis : an international journal on programmed cell death","url":"https://pubmed.ncbi.nlm.nih.gov/19421859","citation_count":22,"is_preprint":false},{"pmid":"21163929","id":"PMC_21163929","title":"Noxa mediates p18INK4c cell-cycle control of homeostasis in B cells and plasma cell precursors.","date":"2010","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/21163929","citation_count":22,"is_preprint":false},{"pmid":"23277490","id":"PMC_23277490","title":"Pro-apoptotic protein Noxa regulates memory T cell population size and protects against lethal immunopathology.","date":"2012","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/23277490","citation_count":22,"is_preprint":false},{"pmid":"36001971","id":"PMC_36001971","title":"Pituitary adenomas evade apoptosis via noxa deregulation in Cushing's disease.","date":"2022","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/36001971","citation_count":21,"is_preprint":false},{"pmid":"32545774","id":"PMC_32545774","title":"Aspirin Induced Glioma Apoptosis through Noxa Upregulation.","date":"2020","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/32545774","citation_count":21,"is_preprint":false},{"pmid":"26181197","id":"PMC_26181197","title":"Sall2 is required for proapoptotic Noxa expression and genotoxic stress-induced apoptosis by doxorubicin.","date":"2015","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/26181197","citation_count":21,"is_preprint":false},{"pmid":"22717582","id":"PMC_22717582","title":"NOXA as critical mediator for drug combinations in polychemotherapy.","date":"2012","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/22717582","citation_count":21,"is_preprint":false},{"pmid":"33557839","id":"PMC_33557839","title":"LiCl induces apoptosis via CHOP/NOXA/Mcl-1 axis in human choroidal melanoma cells.","date":"2021","source":"Cancer cell international","url":"https://pubmed.ncbi.nlm.nih.gov/33557839","citation_count":20,"is_preprint":false},{"pmid":"30949409","id":"PMC_30949409","title":"Targeting sphingosine kinase 2 suppresses cell growth and synergizes with BCL2/BCL-XL inhibitors through NOXA-mediated MCL1 degradation in cholangiocarcinoma.","date":"2019","source":"American journal of cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/30949409","citation_count":20,"is_preprint":false},{"pmid":"18231856","id":"PMC_18231856","title":"The PMAIP1 gene on chromosome 18 is a candidate tumor suppressor gene in human pancreatic cancer.","date":"2008","source":"Digestive diseases and sciences","url":"https://pubmed.ncbi.nlm.nih.gov/18231856","citation_count":19,"is_preprint":false},{"pmid":"26866517","id":"PMC_26866517","title":"Plant Homeo Domain Finger Protein 8 Regulates Mesodermal and Cardiac Differentiation of Embryonic Stem Cells Through Mediating the Histone Demethylation of pmaip1.","date":"2016","source":"Stem cells (Dayton, Ohio)","url":"https://pubmed.ncbi.nlm.nih.gov/26866517","citation_count":19,"is_preprint":false},{"pmid":"33982799","id":"PMC_33982799","title":"NOXA-mediated degradation of MCL1 and BCL2L1 causes apoptosis of daunorubicin-treated human acute myeloid leukemia cells.","date":"2021","source":"Journal of cellular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/33982799","citation_count":19,"is_preprint":false},{"pmid":"31276572","id":"PMC_31276572","title":"Combination of fenretinide and ABT-263 induces apoptosis through NOXA for head and neck squamous cell carcinoma treatment.","date":"2019","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/31276572","citation_count":19,"is_preprint":false},{"pmid":"20085765","id":"PMC_20085765","title":"Noxa is necessary for hydrogen peroxide-induced caspase-dependent cell death.","date":"2010","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/20085765","citation_count":19,"is_preprint":false},{"pmid":"27521572","id":"PMC_27521572","title":"Arsenic trioxide induces Noxa-dependent apoptosis in rhabdomyosarcoma cells and synergizes with antimicrotubule drugs.","date":"2016","source":"Cancer letters","url":"https://pubmed.ncbi.nlm.nih.gov/27521572","citation_count":18,"is_preprint":false},{"pmid":"34903710","id":"PMC_34903710","title":"The BH3-only protein NOXA serves as an independent predictor of breast cancer patient survival and defines susceptibility to microtubule targeting agents.","date":"2021","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/34903710","citation_count":18,"is_preprint":false},{"pmid":"22590594","id":"PMC_22590594","title":"NOXA-induced alterations in the Bax/Smac axis enhance sensitivity of ovarian cancer cells to cisplatin.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/22590594","citation_count":18,"is_preprint":false},{"pmid":"22185759","id":"PMC_22185759","title":"Myocardin-related transcription factor A regulates expression of Bok and Noxa and is involved in apoptotic signalling.","date":"2012","source":"Cell cycle (Georgetown, Tex.)","url":"https://pubmed.ncbi.nlm.nih.gov/22185759","citation_count":18,"is_preprint":false},{"pmid":"37741850","id":"PMC_37741850","title":"NOXA expression is downregulated in human breast cancer undergoing incomplete pathological response and senescence after neoadjuvant chemotherapy.","date":"2023","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/37741850","citation_count":17,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":50152,"output_tokens":10316,"usd":0.152598,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":20756,"output_tokens":4210,"usd":0.104515,"stage2_stop_reason":"end_turn"},"total_usd":0.257113,"stage1_batch_id":"msgbatch_01CNoDbkChHEkgrJnL7BwtGJ","stage2_batch_id":"msgbatch_016Y4x9E9Wg5VQDANj9quSQD","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2003,\n      \"finding\": \"Noxa is a p53 transcriptional target encoding a BH3-only proapoptotic Bcl-2 family protein required for DNA damage-induced apoptosis; Noxa-deficient mice and MEFs show decreased apoptosis in response to DNA damage and oncogene-dependent stress, and Noxa loss combined with Bax loss further increases resistance, placing Noxa upstream of Bax in the intrinsic apoptotic pathway.\",\n      \"method\": \"Gene-targeted knockout mice (Noxa-/-), MEF apoptosis assays, in vivo irradiation model\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic loss-of-function with multiple orthogonal phenotypic readouts, replicated across multiple stress conditions and in vivo, independent of PMID:14500851\",\n      \"pmids\": [\"12952892\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Noxa and Puma are critical BH3-only mediators of p53-dependent apoptosis induced by DNA damage; Noxa deficiency reduces DNA damage-induced apoptosis in fibroblasts but not lymphocytes, while Puma deficiency is broader, also protecting against p53-independent cytotoxic insults.\",\n      \"method\": \"Gene-targeted knockout mice (noxa-/- and puma-/-), apoptosis assays in fibroblasts and lymphocytes\",\n      \"journal\": \"Science (New York, N.Y.)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic KO with defined cell-type-specific phenotypes, independently replicated across two labs (PMID:12952892)\",\n      \"pmids\": [\"14500851\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"The Noxa promoter responds directly to hypoxia via HIF-1alpha transcription factor binding, and Noxa mediates hypoxic cell death involving reactive oxygen species and cytochrome c release; antisense suppression of Noxa rescues cells from hypoxia-induced death and reduces infarction in an ischemia model.\",\n      \"method\": \"Promoter reporter assays, antisense oligonucleotide knockdown, cytochrome c release assay, in vivo ischemia model\",\n      \"journal\": \"The Journal of experimental medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple methods (promoter assay, knockdown, in vivo), single lab\",\n      \"pmids\": [\"14699081\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Proteasome inhibitors induce p53-independent transcriptional upregulation of NOXA mRNA and protein in melanoma and myeloma cells, and NOXA induction is required for mitochondrial apoptosis (cytochrome c, Smac, AIF release, caspase cascade); antisense knockdown of NOXA reduces apoptotic response by 30–50%.\",\n      \"method\": \"Antisense oligonucleotide knockdown, Western blot, cytochrome c/Smac/AIF release assays, caspase activation assays\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — functional knockdown with specific readouts, single lab, multiple cancer lines\",\n      \"pmids\": [\"16024630\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Noxa specifically interacts with the labile anti-apoptotic protein Mcl-1, and the Noxa/Mcl-1 axis functions as an apoptosis rheostat in dividing T cells under glucose limitation; Noxa knockdown protects from glucose deprivation-induced apoptosis while Mcl-1 knockdown sensitizes cells.\",\n      \"method\": \"siRNA knockdown, co-immunoprecipitation, apoptosis assays under glucose deprivation\",\n      \"journal\": \"Immunity\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal functional epistasis with Co-IP, replicated by multiple subsequent labs\",\n      \"pmids\": [\"16782027\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"FKHRL1/FoxO3a transcription factor directly induces Noxa (and Bim) expression, and RNAi knockdown of Noxa decreases FKHRL1-induced apoptosis in neuroblastoma cells; Bcl-2 overexpression (but not dominant-negative FADD) blocks this death, establishing Noxa as a downstream effector linking FKHRL1 to the mitochondrial apoptotic pathway.\",\n      \"method\": \"Tamoxifen-regulated transgene, RNAi knockdown, Bcl-2 overexpression, cytochrome c release assay\",\n      \"journal\": \"Cell death and differentiation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic epistasis with multiple approaches, single lab\",\n      \"pmids\": [\"16888645\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"In bortezomib-treated myeloma cells, Noxa is induced and forms increased Mcl-1L/Noxa complexes, disrupts Mcl-1/Bak complexes, and displaces Bim from Mcl-1, thereby activating Bax/Bak and inducing apoptosis; Mcl-1 cleavage also occurs alongside Noxa induction.\",\n      \"method\": \"Co-immunoprecipitation, Western blot, siRNA knockdown, caspase activation assays\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal Co-IP demonstrating complex formation and displacement, multiple orthogonal methods, independently replicated\",\n      \"pmids\": [\"17545623\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Noxa induction by proteasome inhibitors is directly dependent on the oncogene c-MYC; conserved MYC-binding sites in the NOXA promoter were validated by ChIP and reporter assays; c-MYC knockdown abrogated NOXA induction, and forced c-MYC expression in normal cells enabled NOXA accumulation and apoptosis in response to proteasome blockage.\",\n      \"method\": \"ChIP, promoter-reporter assay, siRNA knockdown, c-MYC overexpression\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — ChIP validation of promoter binding plus gain/loss-of-function experiments, multiple orthogonal methods\",\n      \"pmids\": [\"18042711\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"UVR-induced apoptosis in fibroblasts and skin keratinocytes proceeds via the Bcl-2-regulated (mitochondrial) pathway, with Noxa (a p53 target) playing the dominant initiating role; Noxa deficiency suppresses UVR-induced keratinocyte apoptosis in vivo and in primary MEFs, and in transformed cells where Puma is not induced, Noxa is the primary mediator.\",\n      \"method\": \"Noxa-/- knockout MEFs and mice, UV irradiation, TUNEL/apoptosis assays in skin\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic KO in vivo and in vitro, multiple cell types, clear epistasis\",\n      \"pmids\": [\"17283183\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Puma and Noxa differentially participate in dual p53-induced apoptotic pathways: in normal cells, Puma (but not Noxa) induces MOMP via a calcium/ER-dependent pathway; upon E1A oncoprotein expression, cells become susceptible to Noxa-mediated MOMP via an ER-independent pathway.\",\n      \"method\": \"Noxa-/-, Puma-/- MEFs, E1A expression, MOMP/cytochrome c assays, calcium chelation\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic epistasis with mechanistic pathway dissection, multiple orthogonal approaches\",\n      \"pmids\": [\"17024184\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"E1A expression induces Noxa in p53-deficient cancer cells in a TAp73-dependent manner; E1A activates the TAp73 promoter via E2F1-binding sites, and TAp73 then transcriptionally activates Noxa, establishing p73 as a p53-independent transcriptional activator of Noxa.\",\n      \"method\": \"Promoter-reporter assay, E1A mutant analysis, endogenous mRNA/protein detection, p53-deficient cell lines\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — promoter assays and mutant analysis, single lab\",\n      \"pmids\": [\"15572378\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Bmi1 polycomb group protein directly binds the Noxa gene locus with accompanying H3K27 methylation, recruits other PcG products and Dnmt1, and promotes CpG methylation of the Noxa gene; Bmi1 loss increases Noxa expression leading to enhanced memory T cell death, and Noxa deletion rescues memory Th2 cell generation in Bmi1-/- mice.\",\n      \"method\": \"ChIP, CpG methylation analysis, Bmi1-/- and Noxa-/- genetic crosses, T cell survival assays\",\n      \"journal\": \"The Journal of experimental medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — ChIP demonstrates direct binding, genetic epistasis confirmed by double knockout rescue\",\n      \"pmids\": [\"18411339\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Cisplatin-induced Noxa expression is ERK-dependent and p53-independent; ERK inhibition or siRNA-mediated Noxa ablation both attenuate cisplatin-induced cell death and permit clonogenic survival, establishing an ERK→Noxa axis as critical for platinum drug cytotoxicity.\",\n      \"method\": \"siRNA knockdown, ERK inhibitors, clonogenic survival assay, Western blot\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — siRNA knockdown with functional readout, ERK inhibitor epistasis, single lab\",\n      \"pmids\": [\"20802529\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"NOXA protein is ubiquitinated on at least three primary lysine residues and has a short half-life (~1–2 h) subject to proteasomal degradation; in CLL cells, bortezomib causes a rapid, transcription-independent increase in NOXA protein that precedes cytochrome c release and caspase activation.\",\n      \"method\": \"Western blot, siRNA knockdown, ubiquitination analysis, protein half-life measurement\",\n      \"journal\": \"Haematologica\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ubiquitination mapping and functional knockdown, single lab\",\n      \"pmids\": [\"20378569\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Noxa controls Mcl-1 ubiquitination and proteasomal degradation at the mitochondria by disrupting the USP9X/Mcl-1 interaction: Noxa overexpression decreases USP9X–Mcl-1 binding, increases Mcl-1 polyubiquitination, increases Mule–Mcl-1 interaction, and decreases Mule–USP9X complex, resulting in proteasomal Mcl-1 degradation. Noxa's degradative effect requires its exclusive mitochondrial localization.\",\n      \"method\": \"Co-immunoprecipitation, ubiquitination assay, subcellular fractionation, Noxa overexpression\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal Co-IP and ubiquitination assay, single lab\",\n      \"pmids\": [\"21907705\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Full-length Noxa binds Mcl-1 with Kd ~3.4 nM, Bcl-xL with ~70 nM, and wild-type Bcl-2 with ~250 nM by surface plasmon resonance, demonstrating selectivity but not absolute specificity for Mcl-1; Noxa–Bcl-2 interaction is confirmed by co-pulldown from cells, and Bcl-2 overexpression reduces bortezomib-induced apoptosis.\",\n      \"method\": \"Surface plasmon resonance with recombinant proteins, co-immunoprecipitation, Bcl-2 overexpression/knockdown, apoptosis assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro binding kinetics with recombinant proteins plus cellular validation, multiple orthogonal methods\",\n      \"pmids\": [\"21454712\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Oncogenic H-Ras induces Noxa expression, and Noxa displaces Mcl-1 from Beclin-1, enabling Beclin-1-dependent autophagy and autophagic cell death; Noxa or Beclin-1 silencing reduces Ras-induced autophagy and increases clonogenic survival.\",\n      \"method\": \"siRNA knockdown, co-immunoprecipitation (Noxa–Mcl-1, Mcl-1–Beclin-1), autophagy assays, clonogenic survival\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP showing complex disruption, siRNA epistasis, single lab\",\n      \"pmids\": [\"21353614\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"In neuroblastoma cells, endogenous Noxa associates (by immunoprecipitation) with both Bcl-xL and Mcl-1; shRNA knockdown of Noxa significantly reduces bortezomib-induced apoptosis, while Bcl-xL (but not Mcl-1) overexpression prevents apoptosis, establishing that Noxa neutralizes Bcl-xL in neuronal cells.\",\n      \"method\": \"Co-immunoprecipitation, shRNA knockdown, overexpression of Bcl-xL vs Mcl-1, apoptosis assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP plus functional epistasis, single lab\",\n      \"pmids\": [\"20051518\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"During T cell activation, Noxa is induced and acts as a competitive selector during immune responses: Pmaip1-/- effector T cells display decreased antigen affinity and persistence of subdominant clones; Mcl-1 protein stability is controlled by TCR affinity-dependent IL-2 signaling, defining a Noxa/Mcl-1 axis that enforces affinity-based selection.\",\n      \"method\": \"Pmaip1-/- mice, influenza infection model, TCR affinity measurement, IL-2 signaling analysis\",\n      \"journal\": \"Immunity\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — in vivo genetic KO with mechanistic pathway identification, replicated across multiple antigens\",\n      \"pmids\": [\"20620942\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Noxa recruits MCL-1 from the cytosol to the mitochondria; Noxa mutations in the BH3 domain, C-terminal mitochondrial targeting domain, or ubiquitinated lysines alter both Noxa localization/stability and MCL-1 mitochondrial localization, phosphorylation, and ubiquitination, triggering proteasome-mediated MCL-1 degradation.\",\n      \"method\": \"Noxa mutant expression, subcellular fractionation, phosphorylation/ubiquitination analysis, MCL-1 stability assays\",\n      \"journal\": \"Cell death & disease\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — structure-function mutagenesis with functional readouts, single lab\",\n      \"pmids\": [\"24525728\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"The C-terminal tail of Noxa contains a degron mediating ubiquitylation-independent proteasomal degradation; this degron does not require Mcl-1 interaction for Noxa degradation, but mutation of the C-terminal tail stabilizes both Noxa and endogenous Mcl-1 through BH3-mediated direct interaction.\",\n      \"method\": \"Noxa C-terminal deletion/mutation constructs, proteasome inhibition, co-immunoprecipitation, protein half-life assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro reconstitution-like mutagenesis identifying a defined degron sequence, ectopic placement of degron onto other proteins, single lab\",\n      \"pmids\": [\"24811167\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"NF-κB is required for p53-mediated Noxa induction at the protein level (without affecting Noxa mRNA) and for p73-mediated induction of Noxa mRNA; in NF-κB-deficient MEFs, genotoxin treatment fails to induce p73 activation and Noxa mRNA, and cytochrome c release is compromised.\",\n      \"method\": \"p65-/- knockout MEFs, microarray, cytochrome c release assay, NF-κB inhibition\",\n      \"journal\": \"Cell cycle (Georgetown, Tex.) / Aging\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic KO with mechanistic follow-up, two papers from related labs\",\n      \"pmids\": [\"20160496\", \"20195489\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"miR-200c directly represses Noxa expression by binding a target site in the Noxa 3'UTR, as validated by luciferase reporter assay; miR-200c overexpression reduces basal and proteasome-inhibitor-induced Noxa levels.\",\n      \"method\": \"Luciferase reporter assay with 3'UTR, miR-200c overexpression, RT-PCR, Western blot\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — luciferase reporter validates direct binding site, single lab\",\n      \"pmids\": [\"22615771\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"miR-23a negatively regulates NOXA by binding its 3'UTR; heat shock reduces miR-23a levels, leading to NOXA mRNA accumulation and apoptosis; HSP70 protects cells by maintaining miR-23a stability, thereby suppressing NOXA expression.\",\n      \"method\": \"RT-qPCR, stable miR-23a overexpression/knockdown, apoptosis assays, miR-23a stability measurement\",\n      \"journal\": \"Cell death & disease\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — gain/loss of miR-23a with functional apoptosis readout, single lab\",\n      \"pmids\": [\"25429623\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"NOXA protein is degraded by autophagy: p62 acts as autophagic cargo receptor for NOXA, and three C-terminal lysine residues of NOXA are required for its lysosomal degradation; autophagy inhibition increases NOXA protein levels and promotes apoptosis.\",\n      \"method\": \"Autophagy inhibitors, p62 knockdown, NOXA lysine mutants, protein half-life assays, apoptosis assays\",\n      \"journal\": \"Biochimica et biophysica acta. Molecular cell research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — mutational mapping of lysine residues required for p62-mediated degradation, single lab\",\n      \"pmids\": [\"29758299\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Sall2 transcription factor directly binds conserved sites in the NOXA promoter (validated by EMSA and ChIP) and positively regulates Noxa expression; Sall2-/- MEFs show decreased Noxa induction and reduced apoptosis in response to doxorubicin even in the presence of functional p53.\",\n      \"method\": \"EMSA, ChIP, Sall2-/- MEFs, promoter-reporter assay, apoptosis assays\",\n      \"journal\": \"Cell death & disease\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — ChIP and EMSA validate direct binding, genetic KO epistasis, single lab\",\n      \"pmids\": [\"26181197\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"MLN4924 (NAE inhibitor) causes c-Myc accumulation (as a CRL substrate), which transactivates the PMAIP1 gene encoding Noxa; c-Myc knockdown diminishes Noxa induction, and Noxa siRNA diminishes MLN4924-induced killing in AML; Noxa also neutralizes Mcl-1 to synergize with BCL2 inhibitors.\",\n      \"method\": \"siRNA knockdown of c-Myc and Noxa, Western blot, apoptosis assays, Bax/Bak activation\",\n      \"journal\": \"Cell death and differentiation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — functional epistasis by siRNA, consistent with c-MYC mechanism from PMID:18042711, single lab\",\n      \"pmids\": [\"26045051\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"ATF3 and ATF4 cooperatively bind the CRE element in the NOXA promoter and transcriptionally activate Noxa in a p53-independent manner; ERK1 is involved in cisplatin-induced ATF4 and Noxa induction; ATF3 or ATF4 knockdown reduces cisplatin-induced Noxa expression.\",\n      \"method\": \"Promoter-luciferase reporter assays, siRNA knockdown of ATF3/ATF4, Western blot, ChIP-like binding assays\",\n      \"journal\": \"Molecular oncology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — promoter reporter with CRE mutants plus siRNA epistasis, single lab\",\n      \"pmids\": [\"29352505\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"MARCH5 (mitochondria-associated E3 ubiquitin ligase) is the primary mediator of NOXA-dependent MCL1 degradation in prostate cancer cells; MARCH5 loss prevents Noxa-driven MCL1 ubiquitination and degradation, and MARCH5 inhibition sensitizes cells to BCLXL-targeting BH3 mimetics.\",\n      \"method\": \"MARCH5 knockdown/inhibition, ubiquitination assays, apoptosis assays, MCL1 stability measurement\",\n      \"journal\": \"eLife\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic and pharmacological MARCH5 manipulation with mechanistic ubiquitination readouts, validated across multiple models, replicated by two independent papers (PMID:32015503, PMID:32094511)\",\n      \"pmids\": [\"32484436\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"MARCH5 controls MCL1/NOXA complex levels during steady state and mitotic arrest; MARCH5 inhibition causes NOXA accumulation, sensitizes cancer cells to microtubule-targeting agents, and primes cells that undergo mitotic slippage to die in G1. The E2 enzyme UBE2K and mitochondrial outer membrane protein MTCH2 cooperate with MARCH5 to degrade MCL1 specifically when engaged by NOXA.\",\n      \"method\": \"Genome-wide CRISPR-Cas9 screen, MARCH5 inhibition, MCL1/NOXA co-IP, ubiquitination assays, mitotic arrest experiments\",\n      \"journal\": \"Cell death and differentiation / Cell death and differentiation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — unbiased CRISPR screen identifying MARCH5/UBE2K/MTCH2, validated by Co-IP and ubiquitination, independently replicated in two simultaneous papers\",\n      \"pmids\": [\"32015503\", \"32094511\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Cullin-5 (CUL5) neddylation-mediated ubiquitination is responsible for NOXA proteasomal degradation in colorectal cancer; PRDX1 oligomers promote this by bridging UBE2F and CUL5 to enhance CUL5 neddylation; PRDX1 silencing reduces CUL5 neddylation and extends NOXA protein half-life.\",\n      \"method\": \"Ubiquitination assays, neddylation inhibition, PRDX1 knockdown, Co-IP of UBE2F/CUL5/PRDX1 tricomplex, NOXA half-life measurement\",\n      \"journal\": \"Cell death & disease\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP identifying tricomplex, neddylation inhibition with functional readout, single lab\",\n      \"pmids\": [\"33712558\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"5-Azacitidine induces NOXA transcription via the integrated stress response (ISR) pathway within hours, independent of DNA methylation; NOXA complexes with anti-apoptotic proteins to 'prime' AML cells for venetoclax-induced apoptosis; PMAIP1 CRISPR knockout abolishes venetoclax/5-Aza synergy.\",\n      \"method\": \"CRISPR-Cas9 PMAIP1 knockout, Western blot, qPCR, Co-IP, in vivo xenograft models\",\n      \"journal\": \"Clinical cancer research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — CRISPR KO as definitive loss-of-function, in vitro and in vivo validation, Co-IP of NOXA with anti-apoptotic partners\",\n      \"pmids\": [\"32054729\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Pemetrexed increases Noxa expression through ATF4 and ATF3 upregulation; Noxa upregulation reduces USP9X availability to Mcl-1, promoting Mcl-1 ubiquitination and degradation, leading to apoptosis (Noxa-Usp9x-Mcl-1 axis); Noxa siRNA promotes Usp9x expression.\",\n      \"method\": \"siRNA knockdown of Noxa/ATF4/ATF3/Usp9x, Western blot, Co-IP, apoptosis assays\",\n      \"journal\": \"Cell death & disease\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — siRNA epistasis and Co-IP defining Noxa-Usp9x-Mcl-1 axis, single lab\",\n      \"pmids\": [\"24991768\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"NOXA mRNA is highly expressed but protein is rapidly degraded (T½ ~15–30 min) via ubiquitination and proteasomal degradation in mantle cell lymphoma cells; B-cell receptor signaling and cyclin D1 overexpression contribute to NOXA mRNA expression via PI3K/AKT/mTOR pathway.\",\n      \"method\": \"Protein half-life measurement, ubiquitination analysis, BCR signaling inhibitors, Western blot, mRNA analysis\",\n      \"journal\": \"Cell death & disease\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — protein turnover analysis with pathway inhibitors, single lab\",\n      \"pmids\": [\"24457957\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Noxa is phosphorylated at Ser13 by JNK in H. pylori-infected gastric epithelial cells, causing cytoplasmic retention of Noxa and impaired Mcl-1–Noxa interaction; JNK inhibition restores Mcl-1–Noxa interaction at mitochondria, and overexpression of non-phosphorylatable Noxa enhances mitochondrial apoptosis.\",\n      \"method\": \"In vitro binding assay, immunoprecipitation, confocal microscopy (subcellular localization), phospho-specific analysis, JNK inhibition, Noxa mutant expression\",\n      \"journal\": \"FASEB journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — phospho-mutant functional analysis with Co-IP and localization, single lab\",\n      \"pmids\": [\"25404713\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Myocardin-related transcription factor A (MAL/MRTF-A) directly transcriptionally induces Noxa/Pmaip1 expression via a CArG-like box in its promoter; MAL and SRF are recruited to the Noxa promoter upon G-actin-MAL-SRF pathway activation, and this is sensitive to latrunculin but p53-independent.\",\n      \"method\": \"ChIP, promoter-reporter assay with CArG-box mutants, latrunculin treatment, p53-depletion\",\n      \"journal\": \"Cell cycle (Georgetown, Tex.)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP and promoter mutant validation, single lab\",\n      \"pmids\": [\"22185759\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Hydrogen peroxide induces Noxa protein accumulation via ATF4-dependent Noxa mRNA increase and simultaneous inhibition of Noxa protein degradation; Noxa silencing strongly suppresses H2O2-induced apoptosis, establishing Noxa as a crucial mediator of oxidative stress-induced mitochondrial apoptosis.\",\n      \"method\": \"siRNA knockdown, Western blot, mRNA analysis, Bcl-2 overexpression, Bax/Bak DKO cells\",\n      \"journal\": \"FEBS letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — siRNA knockdown with defined pathway (ATF4→Noxa mRNA + protein stabilization), single lab\",\n      \"pmids\": [\"20085765\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"KLF4 transcription factor binds a specific UV-inducible CRE-like element in the NOXA promoter and mediates ERK-dependent, p53-independent NOXA transcriptional induction; KLF4 knockdown reduces NOXA expression in p53-mutated TNBC cells, and KLF4-inducing compound APTO-253 induces NOXA-mediated apoptosis.\",\n      \"method\": \"Promoter-reporter assay with defined element, KLF4 siRNA knockdown, ERK inhibition, APTO-253 compound treatment\",\n      \"journal\": \"Genes\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — promoter element mapping plus siRNA and pharmacological epistasis, single lab\",\n      \"pmids\": [\"33918002\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"PHF8 histone demethylase promotes loss of repressive H3K9me2 mark from the PMAIP1 transcription start site and activates its transcription; PHF8 loss reduces apoptosis during early ESC differentiation; Pmaip1 knockdown mimics the PHF8-deficient phenotype (decreased apoptosis, promoted mesodermal/cardiac differentiation).\",\n      \"method\": \"PHF8 knockout, ChIP (H3K9me2 at PMAIP1 TSS), pmaip1 knockdown/overexpression, apoptosis and differentiation assays\",\n      \"journal\": \"Stem cells (Dayton, Ohio)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP of histone mark at specific locus with genetic epistasis, single lab\",\n      \"pmids\": [\"26866517\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"RUNX1 inhibition reshapes the epigenetic landscape at the NOXA promoter with H3K27ac enrichment, leading to NOXA upregulation and NOXA-dependent cell death in PDAC; NOXA expression in PDAC marks a subtype with synthetic lethality to RUNX1 inhibition.\",\n      \"method\": \"Genome-wide CRISPR drug screen, NOXA isogenic KO cell lines, ChIP-seq for H3K27ac, RUNX1 gain/loss-of-function, patient-derived organoids\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — unbiased screen with NOXA isogenic validation and ChIP-seq, single lab, patient-derived organoids\",\n      \"pmids\": [\"35197278\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"During oxidative stress, lysosomal membrane permeabilization (LMP) acts upstream of MOMP; LMP induces p53-dependent Noxa expression, and Noxa expression is required for MOMP and subsequent apoptosis; MOMP but not LMP is Noxa-dependent.\",\n      \"method\": \"Noxa siRNA, iron chelation, LMP assays, MOMP assay, p53 pathway analysis\",\n      \"journal\": \"Free radical biology & medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — siRNA and organelle stabilization establishing LMP→Noxa→MOMP order, single lab\",\n      \"pmids\": [\"23770082\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Noxa (along with Bmf and Bim) is induced by arsenic trioxide in myeloma and shown by co-immunoprecipitation to bind Mcl-1, displacing Bak and Bim; Noxa silencing significantly protects myeloma cells from ATO-induced apoptosis; Noxa induction is enhanced by GSH depletion and inhibited by GSH elevation.\",\n      \"method\": \"Gene expression profiling, co-immunoprecipitation, siRNA knockdown, GSH manipulation\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP plus siRNA epistasis, single lab\",\n      \"pmids\": [\"18354037\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Noxa upregulation in melanoma is driven by oncogenic BRAFV600E/MEK/ERK signaling via CREB transcription factor; Noxa promotes constitutive low-level autophagy via MEK/ERK and is required for autophagy-mediated delay of apoptosis under nutrient deprivation.\",\n      \"method\": \"BRAFV600E/MEK inhibitors, CREB reporter assay, Noxa siRNA, autophagy assays\",\n      \"journal\": \"Oncotarget\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple inhibitors with Noxa siRNA epistasis and CREB reporter, single lab\",\n      \"pmids\": [\"25365078\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"NOXA/PMAIP1 is a BH3-only proapoptotic Bcl-2 family protein that is transcriptionally induced by p53, p73, HIF-1α, c-MYC, ATF3/ATF4, ERK/CREB, KLF4, FKHRL1/FoxO3a, and MAL/MRTF-A in response to diverse stresses; it selectively binds and inactivates anti-apoptotic MCL-1 (and to a lesser extent Bcl-xL and Bcl-2), and upon binding recruits MCL-1 to the mitochondrial outer membrane where the E3 ligase MARCH5 (together with UBE2K and MTCH2) ubiquitinates and targets the MCL-1:NOXA complex for proteasomal degradation, thereby releasing BAK/BAX and BIM to trigger mitochondrial outer membrane permeabilization, cytochrome c release, and caspase-dependent apoptosis; NOXA itself is also a highly labile protein degraded by the proteasome (via a C-terminal degron and ubiquitination on multiple lysines, regulated by CUL5/Nedd8 and USP9X) and by autophagy (via p62), and its subcellular localization and function are modulated by JNK-mediated phosphorylation at Ser13; epigenetically, NOXA transcription is repressed by Bmi1-mediated H3K27 methylation and PHF8-regulated H3K9me2, and post-transcriptionally suppressed by miR-200c and miR-23a.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"PMAIP1 (NOXA) is a stress-inducible BH3-only proapoptotic Bcl-2 family protein that couples diverse cellular stresses to mitochondrial outer membrane permeabilization (MOMP) and intrinsic apoptosis [#0, #1]. Genetic loss of Noxa in mice and MEFs blunts apoptosis triggered by DNA damage, UV irradiation, and oncogene-driven stress, placing it upstream of BAX/BAK in the intrinsic pathway, with cell-type-specific dominance over PUMA in fibroblasts and transformed cells [#0, #1, #8, #9]. NOXA acts by selectively binding the labile anti-apoptotic protein MCL-1, with high affinity (Kd ~3.4 nM) and lower affinity for Bcl-xL and Bcl-2 [#15]; this engagement displaces BAK and BIM from MCL-1 to license BAX/BAK activation, cytochrome c release, and caspase activation [#4, #6]. Beyond sequestration, NOXA recruits cytosolic MCL-1 to mitochondria and drives its destruction: the mitochondria-associated E3 ligase MARCH5, cooperating with the E2 UBE2K and the outer-membrane protein MTCH2, ubiquitinates MCL-1 specifically when it is engaged by NOXA, targeting the complex for proteasomal degradation [#28, #29], a process reinforced by NOXA-dependent disruption of the USP9X–MCL-1 deubiquitinating interaction [#14, #32]. NOXA transcription integrates a broad range of signals through p53 [#0], p73 [#10], HIF-1\\u03b1 [#2], c-MYC [#7, #26], FoxO3a/FKHRL1 [#5], the ATF3/ATF4 integrated stress response [#27, #36], ERK/CREB and KLF4 [#12, #37, #42], and the MAL/MRTF-A–SRF axis [#35], while being epigenetically repressed by Bmi1-directed H3K27 methylation and PHF8-regulated H3K9me2 [#11, #38]. NOXA protein is itself highly labile, degraded by the proteasome via a C-terminal degron and multi-lysine ubiquitination under CUL5/neddylation control [#13, #20, #30], and cleared by p62-dependent autophagy [#24]; JNK phosphorylation at Ser13 retains it in the cytoplasm and impairs MCL-1 binding [#34]. NOXA also extends beyond apoptosis to autophagy regulation, displacing MCL-1 from Beclin-1 to enable autophagic responses [#16], and serves a physiological role in affinity-based selection of effector T cells [#18].\",\n  \"teleology\": [\n    {\n      \"year\": 2003,\n      \"claim\": \"Established NOXA as a p53-inducible BH3-only effector genetically required for intrinsic apoptosis, defining its place upstream of BAX in stress-induced cell death.\",\n      \"evidence\": \"Noxa-/- knockout mice and MEFs with DNA-damage and irradiation apoptosis assays, replicated across two labs with cell-type resolution\",\n      \"pmids\": [\"12952892\", \"14500851\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not define the molecular target NOXA engages to trigger MOMP\", \"Cell-type-specific dependence (fibroblasts vs lymphocytes) left mechanistically unexplained\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Showed NOXA induction is not exclusively p53-driven, linking hypoxia to NOXA-dependent death and extending its relevance to ischemic injury.\",\n      \"evidence\": \"HIF-1\\u03b1 promoter reporter assays, antisense knockdown, and in vivo ischemia/infarction model\",\n      \"pmids\": [\"14699081\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct HIF-1\\u03b1 occupancy not confirmed by ChIP\", \"Single lab\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Identified MCL-1 as NOXA's key binding partner and framed the NOXA/MCL-1 ratio as an apoptotic rheostat in metabolically stressed cells.\",\n      \"evidence\": \"Co-immunoprecipitation plus reciprocal siRNA epistasis under glucose deprivation in T cells\",\n      \"pmids\": [\"16782027\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Binding affinity and selectivity not quantified\", \"Mechanism downstream of MCL-1 neutralization not yet resolved\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Demonstrated that NOXA neutralizes MCL-1 by competitive displacement, freeing BAK and BIM to activate the executioner machinery.\",\n      \"evidence\": \"Reciprocal Co-IP showing MCL-1/NOXA complex formation and BIM/BAK displacement in bortezomib-treated myeloma\",\n      \"pmids\": [\"17545623\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not establish whether MCL-1 is degraded or only sequestered\", \"Contribution of MCL-1 cleavage unresolved\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Quantified NOXA's binding selectivity, showing strong but non-absolute preference for MCL-1 over Bcl-xL and Bcl-2.\",\n      \"evidence\": \"Surface plasmon resonance with recombinant proteins plus cellular co-pulldown and apoptosis assays\",\n      \"pmids\": [\"21454712\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Cellular consequences of weaker Bcl-2/Bcl-xL binding context-dependent\", \"Did not resolve in vivo target hierarchy\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Revealed that NOXA actively promotes MCL-1 degradation, not just sequestration, by disrupting the USP9X–MCL-1 deubiquitinase interaction at mitochondria.\",\n      \"evidence\": \"Reciprocal Co-IP, ubiquitination assays, and subcellular fractionation with NOXA overexpression\",\n      \"pmids\": [\"21907705\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"E3 ligase responsible not yet identified\", \"Single lab\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Established that NOXA recruits cytosolic MCL-1 to mitochondria and that NOXA's degron and ubiquitinated lysines couple NOXA stability to MCL-1 turnover.\",\n      \"evidence\": \"Structure-function mutagenesis of NOXA BH3, C-terminal targeting domain, and lysines with MCL-1 stability readouts; C-terminal degron transfer experiments\",\n      \"pmids\": [\"24525728\", \"24811167\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mitochondrial E3 ligase for the recruited complex still unidentified\", \"Relative roles of ubiquitin-dependent vs degron-mediated turnover incompletely separated\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Identified MARCH5 (with UBE2K and MTCH2) as the E3 machinery that ubiquitinates MCL-1 specifically when engaged by NOXA, completing the NOXA→MCL-1 degradation circuit.\",\n      \"evidence\": \"Genome-wide CRISPR screen, MARCH5 genetic/pharmacological manipulation, MCL1/NOXA Co-IP and ubiquitination assays, replicated across three simultaneous papers\",\n      \"pmids\": [\"32484436\", \"32015503\", \"32094511\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis for NOXA-dependent substrate recognition by MARCH5 not defined\", \"Tissue-specific dependence on this axis unclear\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Mapped a broad p53-independent transcriptional network (c-MYC, p73, FoxO3a, ATF3/ATF4, ERK/CREB, KLF4, MAL/MRTF-A) that funnels diverse stresses into NOXA induction.\",\n      \"evidence\": \"ChIP, promoter-reporter assays with element mutants, and gain/loss-of-function across multiple stress and cancer contexts\",\n      \"pmids\": [\"18042711\", \"15572378\", \"16888645\", \"29352505\", \"33918002\", \"22185759\", \"26045051\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Combinatorial logic among these factors at the promoter not resolved\", \"Most validations from single labs in specific cell types\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Defined multilayered control of NOXA abundance through proteasomal degradation (CUL5/neddylation, multi-lysine ubiquitination, C-terminal degron), p62-mediated autophagy, JNK Ser13 phosphorylation, and microRNA repression.\",\n      \"evidence\": \"Ubiquitination and half-life assays, neddylation inhibition, lysine/degron mutants, phospho-mutant localization studies, and 3'UTR luciferase reporters\",\n      \"pmids\": [\"20378569\", \"33712558\", \"24811167\", \"24524772\", \"29758299\", \"25404713\", \"22615771\", \"25429623\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Relative quantitative contribution of proteasomal vs autophagic clearance unclear\", \"How phosphorylation, ubiquitination, and degron use are coordinated unresolved\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Extended NOXA function beyond apoptosis to physiological T-cell affinity selection and to autophagy regulation via MCL-1/Beclin-1 disruption.\",\n      \"evidence\": \"Pmaip1-/- mice in influenza infection with TCR affinity analysis; Co-IP and siRNA epistasis linking NOXA to Beclin-1-dependent autophagy\",\n      \"pmids\": [\"20620942\", \"21353614\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular switch between pro-apoptotic and pro-autophagic NOXA outputs undefined\", \"Physiological non-immune roles of NOXA largely uncharacterized\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How NOXA's binding partner choice, subcellular localization, post-translational state, and degradation route are integrated to dictate apoptosis versus autophagy versus survival outcomes remains unresolved.\",\n      \"evidence\": null,\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No structural model of the NOXA–MCL-1–MARCH5 substrate complex\", \"Quantitative thresholds governing rheostat behavior in vivo not established\", \"Integration of phosphorylation and degradation inputs into functional output undefined\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [4, 6, 15, 17, 41]},\n      {\"term_id\": \"GO:0140313\", \"supporting_discovery_ids\": [4, 6, 16]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005739\", \"supporting_discovery_ids\": [14, 19, 34]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [19, 34]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [0, 1, 6, 9]},\n      {\"term_id\": \"R-HSA-8953897\", \"supporting_discovery_ids\": [2, 27, 36]},\n      {\"term_id\": \"R-HSA-9612973\", \"supporting_discovery_ids\": [16, 24, 42]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"MCL1\", \"BCL2L1\", \"BCL2\", \"USP9X\", \"MARCH5\", \"BECN1\", \"BIM\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":7,"faith_total":7,"faith_pct":100.0}}